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Ras genes are mutated in 15% of human cancers. Ras GTPases operate as
molecular

switches

regulating

cellular

processes

including

proliferation,

differentiation, and apoptosis. The three main isoforms of Ras – H-Ras, K-Ras, and
N-Ras – inhabit distinct nanodomains of the plasma membrane and intracellular
compartments including the Golgi. However, the role of single endogenous Ras
isoforms on these compartments remains unclear as most studies have utilized
ectopically expressed and mutant forms of Ras proteins. In an effort to develop
novel tools that will allow us to abrogate individual endogenous Ras isoforms, we
targeted the catalytic domain of p120RasGAP to the plasma membrane with the
hypervariable region (HVR) of H-Ras (GAP-CTH) or K-Ras (GAP-CTK) and to the
Golgi using the HVR of H-Ras with insertion of a point mutation (GAP-CTH181S).
We performed GST-RBD pull-downs on cells expressing each GAP construct and
stimulated with epidermal growth factor (EGF). We found that GAP-CTH and GAPCTK specifically inhibited H-Ras or K-Ras, respectively. However, we did not detect
any effect of GAP-CTH181S on Ras activation.

Additionally, we used confocal

microscopy to verify the ability of GAP constructs to abrogate Ras activation in
distinct sub-cellular compartments.

We found that GAP-CTH inhibits H-Ras

activation on the plasma membrane, while GAP-CTK inhibits K-Ras activation on
the plasma membrane. On the contrary, GAP-CTH181S inhibited H-Ras activation
on the Golgi.

We also analyzed the effects of these GAP constructs on the

activation of ERK and Akt in response to EGF stimulation. We found that EGF
iii

stimulation of the MAPK pathway was inhibited by GAP-CTK but none of the other
GAP constructs, while Akt activation was not inhibited by any GAP construct.
Finally, we assayed cellular proliferation and differentiation. We found that GAPCTK and GAP-CTH were equipotent inhibitors of cellular growth, whereas GAPCTH181S was less potent. We also found that GAP-CTK and GAP-CTH inhibited
differentiation with similar potency, while GAP-CTH181S was more potent. This
approach may be adapted to investigate any Ras-dependent signaling pathway.
Therefore, it has the potential to become a powerful tool for studying Ras isoformspecific signaling outputs.
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Chapter 1. Literature Review
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1.1 Introduction
Ras genes were originally identified as the oncogenes in the Harvey and
Kirsten sarcoma retroviruses responsible for inducing tumors in rats.

These

retroviral oncogenes were called ras, for rat sarcoma, and were later identified in
mammalian cells as mutated versions of normal cellular ras genes.

Three ras

proto-oncogenes exist in the human genome: H-ras, K-ras, and N-ras (Malumbres
and Barbacid, 2003; Prior et al., 2012). The latest gene, N-ras, was identified in
neuroblastoma cells; however, has not been found in any retrovirus.
Constitutively active ras mutations are present in 15% of human cancers.
Point mutations in codons 12, 13, or 61 make ras oncogenic. There are other
mutations that may convert ras into oncogenes such as codon 146 in K-ras. These
mutations lock Ras in the active state by rendering Ras resistant to the effects of
GTPase activating proteins (Barbacid, 1987; Lau and Haigis, 2009).
Each ras gene encodes a specific Ras isoform except K-ras, which bears two
gene products (K-Ras 4A and K-Ras 4B) generated through alternative splicing
(Capon et al., 1983; McGrath et al., 1983).

All Ras isoforms are expressed

ubiquitously in cells except for K-Ras 4A which is restricted temporally and spatially
to the lung, liver, and kidney (Pells et al., 1997).

Ras isoforms are highly

homologous with nearly identical sequences in the effector, exchange factor, and
guanine nucleotide binding domains (amino acids 1-165), which together comprise
the G domain. The C—terminal hypervariable region (amino acids 166-188/189) is
the only region of Ras proteins that shows significant sequence divergence between
the isoforms (Hancock and Parton, 2005).

2

Ras proteins are 21 kilodalton peripheral membrane GTPases that bind
guanosine triphosphate (GTP) or guanosine diphosphate (GDP) to control signal
transduction cascades. Ras signaling regulates a variety of cellular functions

Figure 1.1. Ras Molecular Switch. At the plasma membrane, Ras proteins
operate as a molecular switch oscillating between an inactive GDP-bound and an
active GTP-bound conformation. In response to an exogenous signal, RasGEFs
are activated and promote the GTP binding of Ras. Consequently, active Ras can
interact with and activate downstream effector proteins. The degree of Ras
activation is tightly controlled by RasGAPs which greatly enhance the ability of Ras
to hydrolyze GTP to GDP.
including proliferation, differentiation, and survival. Two sets of proteins, guanine
nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs)
modulate Ras activity. GEFs stimulate the exchange of GDP for GTP. Ras in the
GTP-bound state is active (Bos et al., 2007; Satoh and Kaziro, 1992); GTP-loading
triggers a conformational change in the Switch 1 (amino acids 30-38) and Switch 2
(amino acids 60-76) regions in the G domain endowing Ras proteins with a high
affinity for downstream effectors (Wittinghofer et al., 1993). In contrast, GAPs act
3

as negative regulators to greatly enhance the intrinsic GTPase activity of Ras to
hydrolyze GTP to GDP rendering Ras inactive (Bos et al., 2007) .
Ras is the founding member of a family containing a multitude of small
GTPases that regulate signal transduction pathways.
comprised of 5 subfamilies:

The Ras superfamily is

Arf, Rab, Ran, Rho, and Ras (Wennerberg et al.,

2005). The Arf subfamily of proteins is involved in vesicular budding (Nie et al.,
2003), while the Rab subfamily is involved in vesicle targeting and fusion (Zerial and
McBride, 2001). The Rho subfamily is responsible for the control of cytoskeletal
organization and cell motility (Etienne-Manneville and Hall, 2002). Finally, Ran is
involved in nucleocytoplasmic transport and cell cycle progression (Pemberton and
Paschal, 2005; Weis, 2003).
The Ras subfamily is subdivided into groups, which share 40-50% sequence
homology with the classical Ras proteins. The Ras protein subfamily includes the
following: Ras (H-Ras, N-Ras and K-Ras), R-ras proteins (R-ras, TC21, and MRas), Rap proteins (Rap1A, Rap1B, Rap2A, and Rap2B), Rheb, and RalA and
RalB. The R-Ras subfamily of proteins regulates mitogenesis and the cytoskeleton
and is mutated in some human tumors (Ehrhardt et al., 2002). Rap proteins are
involved in the control of cell adhesion and spreading mediated by integrin (Bos,
2005; McLeod et al., 2004).

RalA and RalB proteins have various functions

including regulation of cell morphology changes, cell motility, and the activity of
transcription factors (Feig, 2003). Rheb proteins are associated with the control of
cell growth and the cell cycle (Aspuria and Tamanoi, 2004).
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1.2 Ras Processing and Trafficking
1.2.1 Post-translational Modification of the Hypervariable Region
Ras proteins are synthesized as hydrophilic molecules in the cytosol and are
posttranslationally modified by the attachment of a hydrophobic anchor for
membrane association (Mor and Philips, 2006).

The C-terminal hypervariable

region contains two signal sequences that are responsible for targeting Ras proteins
to the cytoplasmic face of the plasma membrane. The first of these sequences is
the CAAX motif (C for cysteine, A for aliphatic amino acids, and X for any amino
acid) located at the extreme C-terminus of the HVR (Hancock et al., 1989). The
CAAX motif undergoes a series of posttranslational modifications.

The first

modification is prenylation of the cysteine by the cytosolic enzyme, protein
farnesyltransferase, which is covalently attached (Hancock et al., 1990; Reiss et al.,
1990; Schaber et al., 1990). Further modification of the CAAX motif occurs on the
cytoplasmic face of the endoplasmic reticulum (Choy et al., 1999).

The AAX

residue is cleaved by a protease called Ras converting enzyme 1 (Rce1)
(Boyartchuk et al., 1997; Gutierrez et al., 1989). Finally, the now C-terminal
farnesylated

cysteine

is

methylated

on

the

α-carboxyl

group

by

isoprenylcysteinecarboxyl methyltransferase (Icmt) (Dai et al., 1998). The CAAX
motif of Ras proteins increases the hydrophobicity of the Ras C-terminus, but is
insufficient for stable membrane binding. A second membrane signal is required for
targeting Ras to the plasma membrane (Hancock et al., 1990). In H-Ras, K-Ras 4A
and N-Ras, this signal is palmitoylation of one or two cysteines upstream of the
CAAX motif by Ras palmitoyltransferase (RPT) (Lobo et al., 2002). RPT is located
on the ER and Golgi apparatus in mammalian cells (Apolloni et al., 2000; Chiu et
al., 2002). While H-ras has two sites for palmitoylation at C181 and C184, K-Ras
5

4A and N-Ras have one site at C180 and Ras and N-Ras. The half-life of palmitate
on H-Ras is 2.4h while the half-life of palmitate on N-Ras is only 20 min. (Baker et
al., 2003; Lu and Hofmann, 1995). In contrast to H- and N-Ras, K-Ras 4B has a
polybasic region of six lysine residues responsible for plasma membrane
association (Hancock et al., 1990).
1.2.2 From the Endoplasmic Reticulum to the Plasma Membrane
Posttranslational modification of the C-terminal CAAX motif of nascent Ras
proteins is completed on the membrane of the endoplasmic reticulum.

Further

modification of H-Ras and N-Ras by RPT occurs upstream of the CAAX motif on the
ER and the Golgi apparatus where H-Ras and N-Ras traffic to the plasma
membrane via the secretory pathway, K-Ras is not palmitoylated and traffics to the
plasma membrane by a route that is unclear; (Hancock, 2003; Swarthout et al.,
2005) however, mechanisms for K-Ras transport have been suggested. One such
mechanism is that the positively charged polybasic region of K-Ras contributes to
diffusion of this isoform down an electrostatic gradient to the negatively charged
lipid head groups on the plasma membrane (Okeley and Gelb, 2004; Roy et al.,
2000). The final hypothesis is that K-Ras transport is dependent upon microtubules
(Chen et al., 2000; Thissen et al., 1997).
1.2.3 From the Plasma Membrane to the Endomembrane
Recent studies have shown that Ras is not permanently anchored to the
plasma membrane, but undergoes retrograde trafficking. H-Ras and N-Ras engage
in a continuous cycle of palmitoylation/depalmitoylation that maintains specific
localization of these proteins to the plasma membrane and Golgi apparatus.

6

Figure 1.2. Processing and Intracellular Trafficking of Ras Proteins. The
extreme C-terminal CAAX motif of Ras proteins is postranslationally modified in a
series of steps that occur in the cytosol and on the surface of the endoplasmic
reticulum (ER). Next, H-Ras and N-Ras, traffic from the endomembrane to the
plasma membrane via the classical exocytic pathway. On the contrary, K-Ras exits
the ER and is transported to the plasma membrane by an alternative pathway that
is independent of the Golgi which has yet to be elucidated. Also shown are the
retrograde pathways for Ras isoforms transported from the plasma membrane to
the endomembrane.

Palmitoylated Ras proteins on the plasma membrane are depalmitoylated by an
unidentified thioesterase causing them to be released from the cytoplasmic face of
the plasma membrane where they diffuse through the cytosol to the Golgi
membrane. Non-palmitoylated H-Ras and N-Ras encounter RPT on the ER and
Golgi and are repalmitoylated (Goodwin et al., 2005; Rocks et al., 2005). After
palmitoylation has occurred, Ras proteins traffic to the plasma membrane via
vesicular transport (Apolloni et al., 2000). In contrast, K-Ras does not undergo
further lipid modification through palmitoylation, but also engages in retrograde
7

trafficking.

In hippocampal neurons, activation of the glutamate receptor induces

Ca2+ influx and the subsequent binding of calmodulin to the polybasic-prenyl motif
of K-Ras. This results in the dissociation of K-Ras from the plasma membrane and
the redistribution of K-Ras to the Golgi apparatus and early/recycling endosomes
(Fivaz and Meyer, 2005).

Like calmodulin, other protein chaperones including

smgGDS, phosphodiesterase 6 delta subunit (PDEδ) and prenylated Rab protein
acceptor protein 1 (PRA1) may be responsible for the transport of K-Ras away from
the plasma membrane. These protein chaperones stimulate the dissociation of KRas and other small GTPases from the plasma membrane (Bhagatji et al., 2010;
Kawamura et al., 1993). Recent studies have emerged elucidating this role for
PDEδ in the intracellular trafficking and signaling of Ras isoforms. The current
model for PDEδ-mediated Ras trafficking demonstrates the extraction of K-Ras and
H-Ras from the (Bhagatji et al., 2010; Kawamura et al., 1993) endomembrane and
plasma membrane, respectively. PDEδ sequesters the farnesyl chain of Ras in a
hydrophobic pocket resulting in the solubilization Ras in the cytosol.

Non-

prenylated small GTPases called Ar12/3 bind to PDEδ stimulating the release of
Ras onto the plasma membrane (K-Ras) and Golgi (H-Ras) (Chandra et al., 2012;
Ismail et al., 2011; Philips, 2012). An alternative mechanism of K-Ras retrograde
trafficking involves phosphorylation of K-Ras on serine 181 by protein kinase C
neutralizing the negative charge of the polybasic domain (Bivona et al., 2006).
Furthermore, K-Ras is in dynamic equilibrium with a pool in the cytosol (Mor and
Philips, 2006).

8

1.3 Ras Guanine Nucleotide Exchange Factors
1.3.1 Son of Sevenless (Sos)
Son of sevenless is a well-characterized cytosolic Ras guanine nucleotide
exchange factor that is responsible for coupling intracellular signals from receptor
tyrosine kinases to Ras proteins (Aronheim et al., 1994). Sos1 and Sos2 are two
isoforms that are ubiquitously expressed in mammalian cells (Chardin et al., 1993).
Although these proteins are highly homologous, Sos2 has a higher binding affinity
for Grb2 than Sos1 suggesting that these GEFs may differentially contribute to
receptor-mediated Ras activation (Bowtell et al., 1992; Yang et al., 1995). The
Cdc25 and Ras exchanger motif (REM) domains of Sos are required for Sosmediated Ras specific nucleotide exchange. The REM domain connects with a
surface of the Cdc25 domain. Ras interacts with Sos entirely through binding of the
Cdc25 domain for nucleotide exchange. The product of this exchange reaction,
GTP-loaded Ras, interacts with a distal allosteric site on Sos that is between the
Cdc25 and REM domains creating a bridge between these domains and enhancing
Ras exchange activity.

This indicates that Sos is subject to positive feedback

regulation by Ras-GTP (Margarit et al., 2003; Sondermann et al., 2004) . The
generally accepted model for how Sos activates Ras on the plasma membrane is as
follows: In response to extracellular stimuli, tyrosine kinase receptors are activated
and undergo autophosophorylation at tyrosine residues.

In the cytosol, Sos is

bound to Grb2 through the interaction of its carboxyl terminus proline-rich
sequences and Src homology 3 domain of Grb2 (Buday and Downward, 1993;
Egan et al., 1993; Li et al., 1993).

The Grb2-Sos complex translocates to the

plasma membrane where the Src homology 3 domain of Grb2 associates with the
phosphorylated residues of the receptor. Sos is brought into close proximity to Ras
9

on the plasma membrane and GDP/GTP exchange is catalyzed (Lowenstein et al.,
1992; Rozakis-Adcock et al., 1993). This model has undergone review based on a
recent study showing that a lipid-protein interaction with phosphatidic acid (PA) is, in
fact,

Figure 1.3. The Activation of Ras Proteins on the Plasma Membrane. (A) Ras
isoforms are activated by the RasGEF Sos on the plasma membrane. The process
is initiated by the binding of a growth factor to a receptor tyrosine kinase (RTK)
followed by autophosphorylation of specific tyrosine residues within the cytoplasmic
tail of the receptor. These events promote the translocation of Grb2/Sos
heterodimers from the cytosol to the plasma membrane allowing Sos to stimulate
the exchange of GDP for GTP on Ras, rendering Ras proteins active. (B) A recently
discovered component of Ras activation by the EGF receptor on the plasma
membrane is PLD2. On the plasma membrane, phosphatidic acid (PA) produced
by PLD2 recruits Sos, facilitating the activation of Ras. (C) Ras activation occurs
downstream of the G-protein-coupled receptor (GPCR). Heterotrimeric G-proteins
are dissociated into Gα and Gβγ subunits following ligand binding of the GPCR.
Then, the Gβγ subunit stimulates the recruitment of PI3Kγ to the plasma
membrane, resulting in Src activation. Tyrosine residues within the EGFR and Shc
are phosphorylated by activated Src. Shc then recruits Grb2/Sos complex to the
plasma membrane resulting in the activation of Ras.
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accountable for recruitment of Sos to the plasma membrane upon EGFR
stimulation. PA is generated by phospholipase D2 (PLD2) via the hydrolysis of
phosphatidylcholine (PC) (Zhao et al., 2007).
1.3.2 Ras Guanine-Nucleotide Release Factors (RasGRFs)
The RasGRF family of guanine-nucleotide exchange factors is comprised of
two isoforms, RasGRF1 and RasGRF2.

The expression of these proteins is

restricted to specific tissue locations. Both isoforms are predominantly expressed in
the brain. Traces of RasGRFs expression have also been detected in the heart,
lung, and pancreas. The regulation of RasGRFs in signal transduction occurs in a
different manner than Sos proteins.

RasGRF1 and RasGRF2 are activated in

response to elevated levels of cytosolic calcium. A signaling pathway involving
activation of the N-methyl-d-aspartate (NMDA) receptor in neuronal cells by
ionomycin is known to trigger calcium-dependent activation of RasGRFs.

This

activation is mediated by binding of calmodulin to the IQ motif of RasGRFs, which
stimulates the translocation of RasGRFs to the plasma membrane (Farnsworth et
al., 1995).

Once at the plasma membrane RasGRFs stimulate Ras guanine

nucleotide exchange. Although ionomycin preferentially activates RasGRF1 at the
plasma membrane, it also induces activation of RasGRF1 at the endoplasmic
reticulum at lower levels.

RasGRF1 is also activated in response to ligand

stimulation of the G-protein coupled receptor (GPCR). Full activation of RasGRF1
requires serine and tyrosine phosphorylation events and the release of calcium from
intracellular stores in response to inositol-(1,4,5)-triphosphate (IP3) generated by
GPCR-activated phospholipase C (Tian et al., 2004). Non-receptor tyrosine kinases
such as the Cdc42-associated kinase 1 (ACK1) and Src (sarcoma) have also been
shown to phosphorylate RasGRF1 (Kiyono et al., 2000).
11

1.3.3 Ras Guanyl-Releasing Proteins (RasGRPs)
Another family of Ras guanine nucleotide exchange factors is the Ras
guanyl-releasing proteins, RasGRP1, RasGRP2, RasGRP3, and RasGRP4

Figure 1.4. Activation of Ras by RasGRFs. In neurons, stimulation of the Nmethyl-D-aspartate glutamate ligand-gated ion channel receptor (NMDAR)
generates an influx of calcium (Ca2+). Consequently, calmodulin (CaM) binds to the
IQ domain of RasGRF. This prompts the translocation of RasGRFs to the plasma
membrane by an unidentified mechanism, resulting in activation of RasGRF.
RasGRF activation also occurs downstream of the G-protein coupled receptor
(GPCR). Upon stimulation of the GPCR, phospholipase C (PLC) is activated
causing the production of inositol-(1,4,5)-triphosphate (IP3) which in turn stimulates
intracellular Ca2+ release, resulting in RasGRF activation. Cdc42-associated kinase
1 (ACK1) may contribute to RasGRF activation by phosphorylation.
(Mitin et al., 2005). Like RasGRFs, RasGRP proteins have a restricted pattern of
expression. RasGRP1 and 3 are predominantly expressed in the adult brain and
lymphoid tissues with some expression present in the kidney (Ebinu et al., 1998;
Tognon et al., 1998; Yamashita et al., 2000). RasGRP2 is expressed in a wide
range of tissues including the brain, heart, lungs, pancreas, and kidney (Clyde-
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Smith et al., 2000).

RasGRP4 is expressed in peripheral blood mononuclear

leukocytes in adults, while fetal expression is distributed in the heart, lung, kidney,
liver, and thymus (Yang et al., 2002). In addition to the catalytic domains REM and
CDC25 that all Ras guanine nucleotide exchange factors possess, RasGRPs
contain calcium binding EF hands and diacylglycerol (DAG) binding C1 domains.
The deletion of these domains results in the inability of RasGRP1 to activate Ras
and transform fibroblasts. The membrane recruitment and activation of RasGRPs1,

Figure 1.5. Activation of Ras by RasGRPs. Upon activation of the TCR, the
scaffold protein LAT is phosphorylated by Zap70 which provides binding sites for
the recruitment of PLC and the GRB2/Sos complex. PLC then hydrolyzes PtdInsP2
which in turn generates DAG and InsP3. Calcium is released from intracellular
stores by InsP3 recruiting the RasGAP CAPRI to the plasma membrane; therefore
Ras activation by Sos is prevented. At the same time, calcium along with DAG
drive RasGRP1 to the Golgi, where H- and N-Ras are activated. Co-activation of
LFA-1 with the TCR results in increased levels of DAG through PLD2 and PAP.
These DAG levels are sufficient to recruit RasGRP1 to the plasma membrane
where Ras is activated.
3, and 4 is directly dependent on DAG binding to their C1 domains (Ebinu et al.,
1998). In contrast, RasGRP2 is constitutively associated with the membrane by N13

terminal myristoyl and palmitate modifications, but its ability to stimulate nucleotideexchange on Ras is also enhanced by DAG.

DAG production is coupled to

phospholipase C activity, which generates the second messengers, DAG and IP3
(Clyde-Smith et al., 2000). Furthermore, RasGRP1 and RasGRP3 are the only
RasGEFs that are localized in the Golgi apparatus (Caloca et al., 2003).
1.4 Ras GTPase-Activating Proteins (RasGAPs)
1.4.1 p120 RasGAP
p120 RasGAP was the first GTPase activating protein (GAP) to be
discovered (Trahey and McCormick, 1987). Inactivating mutations in the RASA1
gene, which codes for p120GAP, are found in patients with a capillary malformationarteriovenous malformation syndrome (Eerola et al., 2003). p120 RasGAP helped
to elucidate the reason behind missense mutations at Ras residues G12 or Q61 that
result in constitutively active Ras. These Ras mutant proteins are insensitive to
GAP activity and are trapped in the active GTP bound conformation. p120 RasGAP
interacts with Ras at the effector site (Der et al., 1986; Scheffzek et al., 1997;
Seeburg et al., 1984). The mechanism of p120 RasGAP-assisted GTP hydrolysis
involves the stabilization of glutamine at position 61 of Ras by GAP. An arginine
provided by GAP is positioned into the phosphate-binding site and stabilizes the
transition state by neutralizing the negative charge. Mutation of glutamine 61
abolishes GAP-induced hydrolysis (Ahmadian et al., 1997; Coleman et al., 1994).
p120 RasGAP is a widely expressed cytoplasmic protein that is comprised of
several domains including a GAP catalytic domain and an N-terminal region
containing two SH2 motifs, one SH3 motif, a pleckstrin homology domain, and the
calcium dependent lipid binding motif, C2. The two SH2 motifs are responsible for
interactions

with

activated

tyrosine

kinase
14

receptors

and

other

tyrosine

phosphorylated proteins (Cleghon et al., 1998; Kaplan et al., 1990). p120 RasGAP
is also a caspase substrate. When cleaved by caspases this protein negatively or
positively regulates apoptosis in a manner that is dependent on caspase activation
(Yang and Widmann, 2001).
1.4.2 Neurofibromin
Neurofibromin is a large cytoplasmic protein encoded by NF1, a tumor
suppressor gene that is lost in the autosomal dominant disease neurofibromatosis
type 1 (Dasgupta and Gutmann, 2003). Clinically, this disease is characterized by
learning disabilities, bone deformities, nervous tumors, and gliomas. Neurofibromin
is expressed mostly in Schwann cells, neurons, astrocytes, leukocytes, and
oligodendrocytes (Dasgupta and Gutmann, 2003; Jouhilahti et al., 2011).
The known functional domains of neurofibromin are limited to the Sec14/PH
module and the RasGAP catalytic domain. The Sec14/PH module lies at the Cterminus of the catalytic domain and consists of a Sec 14 homology segment and a
neighboring

PH-like

domain.

The

Sec

14

homology

segment

binds

to

glycerophospholids and mediates the exchange of phosphatidylinositol for
phosphatidylcholine between membrane compartments, a common process
associated with lipid metabolism and membrane trafficking. Association of the PHlike domain with the Sec-14 homology segment through an interface allows for
regulation of phospholipid binding. A specific region of neurofibromin shares
sequence homology with the RasGAP catalytic domain of p120 RasGAP referred to
as the GAP related domain (GRD) (Trovo-Marqui and Tajara, 2006). This domain
has a higher affinity for H-Ras and N-Ras than p120 RasGAP. The RasGAP domain
activity of neurofibromin is inhibited by three lipids: arachidonate, phosphatidate,
and phosphatidylinositol-4,5-biphosphate (Bollag and McCormick, 1991).
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1.4.3 GAP1
GAP1 is another family of RasGAPs that includes two subgroups GAP1m and
GAP1IP4BP,and Calcium promoted Ras inactivator (CAPRI) and Ras-GTPaseactivating-like protein (RASAL) (Lockyer et al., 1997; Yarwood et al., 2006). Both
GAP1m and GAP1IP4BPare ubiquitously expressed and are activated by binding of
phosphoinositides to the pleckstrin homology domain found in both proteins
(Lockyer et al., 1999).

GAP1IP4BPconstitutively associates with the plasma

membrane (Lockyer et al., 1997) while GAP1m translocates from the cytosol to the
plasma membrane in response to EGF stimulation (Lockyer et al., 1999). CAPRI
and RASAL are activated by calcium influx, but differ in their response to calcium.
CAPRI translocates from the cytosol to the plasma membrane when intracellular
calcium levels rise (Lockyer et al., 2001; Walker et al., 2004) whereas RASAL
cycles between the cytosol and the plasma membrane in response to the frequency
of calcium oscillations (Liu et al., 2005; Walker et al., 2004).
1.4.4 Other GAPs
SynGAP is a constitutively membrane associated RasGAP that is mainly
present in the brain (Kim et al., 1998). There is little information known about the
regulation of this RasGAP; however, its activity is upregulated by serine
phosphorylation by calmodulin-dependent protein kinase II (CaMKII) (Oh et al.,
2004). Similarly, very little is known about the regulation of the activity of DAP2IP,
an abundantly expressed RasGAP in mammalian cells (Wang et al., 2002).
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1.5 Ras Effectors
1.5.1 Raf
The Raf kinase family was the first Ras effector identified and is the most
thoroughly studied (Moelling et al., 1984; Rapp et al., 1983).

The mammalian

genome contains 3 Raf genes that encode for three isoforms of Raf, C-Raf, A-Raf,
and B-Raf, which are serine/threonine kinases. Alternative spliced forms of A-Raf
and B-Raf have also been identified.

Oncogenic B-RAF mutations have been

identified in approximately 70% of human melanomas, making the involvement of BRaf in oncogenesis far greater than either C-Raf or A-Raf (Dhomen and Marais,
2007).
There are two regions of Raf proteins that associate with GTP-bound Ras:
an N-terminal Ras binding domain (RBD) and an adjacent cysteine rich domain
(CRD). These motifs bind to specific domains of Ras. The RBD interacts with the
switch 1 region of Ras and the CRD binds to the switch II region. In its inactive
state, C-Raf is present in the cytoplasm bound to the scaffold protein 14-3-3. The
activation of C-Raf is highly complex and involves membrane recruitment,
phosporlyation/dephosporylation events, and protein-protein interactions. Binding
of GTP-loaded Ras to Raf via the RBD and CRD results in the recruitment of Raf to
the plasma membrane (Bondeva et al., 2002; Stokoe et al., 1994; Thorson et al.,
1998). The recruitment event is necessary but not sufficient for Raf activation.
Additionally, dephosphorylation of Ser43, Ser233, and Ser259 and phosphorylation
of Ser621, Ser338, Tyr341, Thr491 and Ser494 are required. Dephosphorylation of
Ser43 removes the steric hindrance on the binding of the N-terminus of Raf to Ras.
Dephosphorylation of Ser259 displaces 14-3-3 from this binding site, while
phosphorylation of Ser621 allows 14-3-3 to bind to the C-terminus of Raf.
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Phosphorylation of Ser338 and Tyr341 imparts a negative charge to the N-region of
C-Raf. The activation of A-Raf follows a similar pattern to that of C-Raf, while the
activation of B-Raf is solely dependent upon Ras alone (Chong et al., 2001;
Dhomen and Marais, 2007; Dumaz et al., 2002).
Acitve Raf phosphorylates two downstream effectors, MEK1 and MEK2 on
two serine residues in the activation segment. Subsequently, MEK1 and MEK2
activate ERK1 and ERK2 through phosphorylating threonine and tyrosine residues
in their activation segments . ERK phosphorylates a multitude of cytosolic and
nuclear substrates, including transcription factors, cytoskeletal proteins, and kinases
and phosphatases. This signaling cascade of Ras/Raf/MEK/ERK is known as the
MAP kinase pathway.

This pathway leads to the regulation of cellular

differentiation, proliferation, and survival and is commonly mutated in human
cancers There are several scaffolding proteins that modulate the activation of the
MEK-ERK cascade, including the Kinase suppressor of Ras-1 (KSR1), Connector
enhancer of KSR (CNK), Paxillin and MEK partner-1 (MP1) (Kolch, 2005; Shaul and
Seger, 2007; Yoon and Seger, 2006).
Another interesting aspect of Raf signaling is the formation of C-Raf/B-Raf
heterodimers. This is dependent on GTP-Ras and 14-3-3. These heterodimers
have

increased

kinase

activity

compared

to

B-Raf

and

C-Raf

monomers/homodimers due to dramatically elevated C-Raf kinase activity
stimulated by B-Raf.

In contrast, C-Raf has no effect on B-Raf kinase activity

(Garnett et al., 2005).
1.5.2 Phosphatidylinositol 3-Kinase (PI-3K)
A second Ras effector essential for Ras transforming activity is PI3-K. PI3kinases are heterodimers with a p85 regulatory subunit and a p110 catalytic
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subunit. The p85 subunit inhibits p110 catalytic activity of PI3-K. The p110 subunit
contains domains for membrane anchoring, interactions with p85 and Ras, and
kinase activity.
mechanisms:

PI3-kinases can be activated through two independent

binding of Ras-GTP to the p110 subunit or binding of p85 to

phosphotyrosine residues on activated receptor tyrosine kinases, either directly or
indirectly. The p85-RTK interaction recruits the inactive p85-p110 complex to the
plasma membrane and relieves the inhibitory effects of p85 on p110 (Krasilnikov,
2000). Activated p110 catalyses the phosphorylation of the 3’ hydroxyl group of
phosphatidylinositol derivatives such as phosphatidylinositol-(4,5)-bisphosphate
(PIP2) to generate phosphatidylinositol-(3,4,5)-triphosphate (PIP3). PIP3 activates
its main effector, AKT, and other downstream effector pathways. PIP3 signaling is
terminated by the action of phosphatases including PTEN, SHIP1, and SHIP2
(Vivanco and Sawyers, 2002).
The activation of AKT is dependent upon plasma membrane recruitment and
phosphorylation at Thr308 and Ser473.

The membrane recruitment of AKT is

mediated by the direct association of its N-terminal pleckstrin homology (PH)
domain with the membrane-associated PIP3 (Rodriguez-Viciana et al., 1994).
Phosphorylation of Thr308 is catalyzed by the PIP3-dependent protein kinase
(PDK1), while Ser473 is phosphorylated by PDK2 (Alessi et al., 1997).

19

Figure 1.6. Activation of Phosphatidylinositol 3-kinase (PI3-K) by Ras.
Activation of the EGF receptor results in binding of the regulatory subunit of PI3-K,
p85, to phosphorylated tyrosine residues of the receptor. Consequently, the
catalytic subunit of PI3-K, p110, is recruited to the plasma membrane. PI3-K
activity is enhanced further by the interaction between p110 and RasGTP.
Phosphorylation of PIP2 by PI3-K produces PIP3 which recruits and activates
PDK1. PDK1 phosphorylates and activates protein kinase B (PKB) also known as
Akt.
AKT is a serine/threonine kinase which phosphorylates numerous substrates
including BAD, mTOR, and MDM2 to mediate its effects in cell survival and
proliferation. PI3-kinases also signal through non-AKT pathways, including Cdc42
and Rac1 which regulate cell motility, and SGK which regulates survival (Vivanco
and Sawyers, 2002).
1.6 Non-Redundant Functions of Ras Isoforms
It is well established that Ras isoforms are highly homologous; however,
several lines of evidence demonstrate that the functions of each Ras isoform are
non-redundant. Nonredundance was first suggested by analyses of the mutation
rates of ras genes in cancers. Ras mutations occur frequently in certain cancers,
but the mutation rates of different isoforms vary significantly across different tumors.
For example, mutations in the K-ras gene are associated with about 90% of
pancreatic cancers, 50% of colorectal cancers, and 35% of non-small cell lung
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cancers.

In contrast, H-ras mutations occur in 10% of transitional cell bladder

cancers, while N-ras mutations occur in 30% of acute leukemia (Downward, 2003;
Roberts and Der, 2007). Interestingly, N-Ras mutations cause Noonan syndrome, a
common autosomal dominant congenital disorder characterized as a type of
dwarfism (Cirstea et al., 2010). Among all ras mutations in cancers, K-ras accounts
for more than 85%, 12% in N-ras, and 2% in H-ras (Lau and Haigis, 2009).
Table 1.1 Frequency of Ras Mutations in Different Tumors
Tumor Type
Frequency (%)
Pancreas
Lung adenocarcinoma (non-small-cell)
Colorectal
Thyroid (Follicular)
Thyroid (Undifferentiated papillary)
Seminoma
Melanoma
Bladder
Liver
Kidney
Myelodysplastic syndrome
Acute myelogenous leukemia
(Downward, 2003)

90 (K)
35 (K)
45 (K)
55 (H, K, N)
60 (H, K, N)
45 (K, N)
15 (N)
10 (H)
30 (N)
10 (H)
40 (N, K)
30 (N)

Studies in knockout mice provide further evidence for functional divergence
between Ras isoforms revealing that only the K-Ras 4B isoform is essential for
mouse development. K-ras

-/-

mice die at two weeks of gestation with defects in

myocardial and neural development (Johnson et al., 1997; Koera et al., 1997;
Umanoff et al., 1995) while H-ras-/- and H-ras-/-/N-ras-/- mice display normal growth,
fertility, and viability (Esteban et al., 2001; Ise et al., 2000). Additionally, K-ras 4a-/mice show normal growth and fertility with no abnormal histological pathology up to
20-23 months of age (Plowman et al., 2006; Plowman et al., 2003).
Moreover, all Ras isoforms share a common set of effectors, but engage
them with different efficiencies. In transformed fibroblasts, N-Ras binds C-Raf more
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effectively than H-Ras. The oncogenic properties of N-Ras are mediated by C-Raf
in melanomas. Mutant K-Ras recruits and activates C-Raf with a higher efficiency
and potency than N-Ras or H-Ras (Voice et al., 1999; Yan et al., 1998). K-Ras also
activates the Rac pathway more efficiently than H-Ras (Walsh and Bar-Sagi, 2001),
while H-Ras is a more potent activator of PI3K than K-Ras (Voice et al., 1999; Yan
et al., 1998).
1.7 Compartmentalization of Ras Signaling
1.7.1 Signaling on Plasma Membrane Nanodomains
An intriguing area in Ras biology is compartmentalized signaling, In
particular, at the plasma membrane.

Sophisticated high resolution imaging

including electron microscopy (EM), fluorescence resonance energy transfer
(FRET), and single particle trafficking (SPT) methods have led to a definitive picture
of Ras organization on the plasma membrane (Plowman and Hancock, 2005). The
plasma membrane represents a complex mosaic of microdomains that results from
the biophysical properties of the constituent lipids, cholesterol, and the actin
cytoskeleton and the lateral assembly of sphingolipids and cholesterol into liquid
ordered domains; therefore, imposing a non-random distribution on proteins across
different nanoscale domains. The plasma membrane is the major Ras signaling
platform and is the site where Ras proteins function in distinct nanodomains called
nanoclusters.

(Hancock, 2006; Kusumi et al., 2005b; Mayor and Rao, 2004).

These nanoclusters are transient dynamic structures that are assembled by a
complex interplay between components of Ras proteins and the plasma membrane.
Vital components of the Ras protein include the farnesyl group and adjacent
sequences of the hypervariable region. Vital components of the plasma membrane
include the actin cytoskeleton, scaffold proteins, and phospholipid/ cholesterol
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composition (Harding and Hancock, 2008b). Ras nanoclusters are comprised of
~40% of Ras proteins that are arranged into clusters of 6-8 proteins on the plasma
membrane. The remaining Ras proteins are randomly arrayed as monomers on the
plasma membrane (Hancock and Parton, 2005; Plowman et al., 2005; Prior et al.,
2003). Ras nanoclusters have a radius of ~9nm and a lifetime of 0.1-0.4s (Hancock
and Parton, 2005; Kusumi et al., 2005a; Kusumi et al., 2005b; Murakoshi et al.,
2004; Plowman et al., 2005).

The function of Ras nanoclusters in Ras signal

transduction is to recruit Ras effectors such as Raf, MEK, and ERK. Inhibition of
Ras nanocluster assembly abrogates Ras signal output even if Ras is active and
localized to the plasma membrane (Plowman et al., 2008; Plowman et al., 2005;
Tian et al., 2007). Additionally, in MAPK signaling, Ras nanoclusters function as a
digital switch converting graded ligand inputs into fixed outputs of ERK.

The

generation of Ras nanoclusters that are in direct proportion to ligand input allows
cells to build an analogue-digital-analogue circuit relay. This signal is transmitted in
high fidelity across the plasma membrane (Harding et al., 2005; Inder and Hancock,
2008; Inder et al., 2008).
Ras isoforms are localized to spatially distinct, non-overlapping nanoclusters
on the plasma membrane. GTP-bound H-Ras is mainly localized to cholesterol
independent nanoclusters that are stabilized by galectin-1, a cytosolic scaffold
protein. In its inactive, GDP- bound conformation, H-Ras is present in cholesterol
dependent nanoclusters that require an intact actin cytoskeleton (Belanis et al.,
2008; Plowman et al., 2005; Prior et al., 2001; Prior et al., 2003).

The GTP-

dependent lateral segregation of N-Ras is opposite to that of H-Ras. When GTPloaded, N-Ras is present in cholesterol dependent domains, but shifts to cholesterol
independent domains when GDP-loaded (Roy et al., 2005). On the contrary, GDP23

and GTP-bound K-Ras is localized to cholesterol-independent nanoclusters that are
partially dependent upon the actin cytoskeleton. GTP-loaded K-Ras requires the
galectin-3 scaffold and GDP-loaded K-Ras does not (Elad-Sfadia et al., 2004;
Plowman et al., 2005; Prior et al., 2003).
1.7.2 Signaling on Endosomes
Endosomes were the first intracellular compartment implicated in Ras
signaling. Subcellular fractionation studies provided initial insights into endosomal
Ras signaling with evidence of Shc, Grb2, Sos, and C-Raf localization to
endosomes following EGF stimulation (Di Guglielmo et al., 1994; Pol et al., 1998).
Additionally, protein tyrosine kinase receptors (PTKRs), such as the EGF receptor
(EGFR), were demonstrated to remain active upon internalization on endosomes
(Burke et al., 2001).

Moreover, Ras isoforms are localized to endosomes in

response to growth factor stimulation or ubiquitination (Jura et al., 2006; Pol et al.,
1998). H-Ras and N-Ras signaling require endocytosis, while K-Ras signaling does
not (Omerovic et al., 2007; Roy et al., 2002).

Recent work revealed that

palmitoylated Ras proteins (H-Ras and N-Ras) are directed to recycling endosomes
(REs). The current belief is that REs also serve as a way-station for Ras proteins
as they traffic to the plasma membrane (Misaki et al., 2010).
1.7.3 Signaling on the Golgi
Live cell imaging using GFP-RBD, a probe that selectively binds Ras-GTP,
showed that the Golgi apparatus and plasma membrane are both sites for Ras
activation.

Activation of Ras on the plasma membrane occurs rapidly and

transiently (onset within 1 minute, 10 minute duration) after stimulation with the
epidermal growth factor (EGF), whereas activation of Ras on the Golgi is sustained
and delayed (onset within 10 minutes, 60 minute duration).
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The Ras isoforms

involved are believed to be H-Ras and N-Ras, since these isoforms shuttle between
the plasma membrane and the Golgi. K-Ras 4B is not present on the Golgi and is
not thought to engage in this process. Interestingly, activation of the Golgi pool of
Ras was found to occur independently of the endocytic pathway when it was
unaffected by dominant negative epsin or a temperature block, factors that block
endocytosis and vesicular transport respectively (Bivona and Philips, 2003; Chen et
al., 1998; Chiu et al., 2002).
Drawbacks of GFP-RBD include its inability to detect endogenous activated
Ras unless a GEF is overexpressed and its dependence on the overexpression of
wild-type Ras isoforms (Quatela and Philips, 2006).

A similar probe was later

created which involved the use of C-terminally tagged RBD constructs with GFP
(Walker and Lockyer, 2004) and the use of both the RBD and CRD domains of CRaf tagged with GFP. Expression of the latter (RBD-CRD) generates a stronger
interaction with Ras on the membrane than RBD alone. In striking contrast, active
Ras was only observed on the plasma membrane (Bondeva et al., 2002).
Other methods for investigating Ras signaling on the Golgi apparatus have
involved the use of Flourescence Resonance Energy Transfer (FRET)-based Ras
activity probes. The first attempt was use of the novel Raichu-Ras FRET probe that
assayed active Ras by reporting the sum of GEF and GAP activities. The probe
localized exclusively to the plasma membrane. An explanation for this is that the
Raichu-Ras probe included the HVR of K-Ras for membrane attachment (Mochizuki
et al., 2001; Walker and Lockyer, 2004).

Subsequent studies to detect FRET

between YFP-RBD and active CFP-Ras also failed to report active Ras on the Golgi
(Jiang and Sorkin, 2002; Ohba et al., 2003). Additionally, the use of full-length CRaf as a FRET reporter for active Ras has given mixed success to demonstrate the
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Golgi as a site for Ras signaling. This may be due to the complex regulation of its
membrane recruitment (Bondeva et al., 2002; Hibino et al., 2003; Jiang and Sorkin,
2002).
Despite the inconsistency in Golgi studies, there are several lines of
evidence that demonstrate Golgi signaling from Ras is important. Research in T
cells show that low-grade stimulation of the T cell receptor is specific to N-Ras and
only occurs on the Golgi (Perez de Castro et al., 2004). Additionally, in thymic
selection, negative selection is related to ERK dynamics on the plasma membrane,
while positive selection correlates with Golgi-mediated ERK activation (Daniels et
al., 2006).

Furthermore, activation of ERK on the Golgi generates a graded

response, and plasma membrane-mediated ERK activation produces a digital or
switch-like response (Inder and Hancock, 2008).
The mechanism behind Golgi-associated activated Ras was revealed in
Jurkat T cells stimulated by the activation of the T-cell receptor. Phospholipase Cγ
(PLCγ) is responsible for activating Ras on the Golgi. PLCγ is an enzyme that
produces diacylglycerol (DAG) and inositol triphosphate (IP3). IP3 releases calcium
into the cytosol which leads to the accumulation and recruitment of the Ras GEF,
RasGRP1, on the Golgi. RasGRP1 is controlled by both DAG and calcium and has
affinity for the Golgi membrane. The requirement of RasGRP1 was revealed when a
dominant interfering mutant of this GEF inhibited Ras activation of the Golgi and
silencing of RasGRP1 with short interfering RNA abrogated the activation of Ras on
this compartment. Furthermore, calcium promoted inactivator (CAPRI), a negative
regulator of R\as, was shown to inhibit Ras activation at the plasma membrane in
Jurkat T cells (Bivona et al., 2003).
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1.7.4 Signaling on the Endoplasmic Reticulum (ER)
Whether or not Ras can signal from the ER remains controversial.

The

strongest evidence of signaling on the ER comes from studies in yeast.

In

Saccharomyces cerevisiae, an ER-restricted Ras effector was discovered known as
ER-associated Ras inhibitor (ERi1). The function of this protein is to preferentially
bind to the effector loop of GTP-loaded Ras to inhibit Ras localized to the ER
(Sobering et al., 2003). Eri1 is a component of GPI-GlcNAc transferase, an enzyme
involved in the rate-limiting step in the biosynthesis of GPI-anchors. Interestingly,
GTP-bound Ras2 binds to and inhibits the activity of this enzyme in the absence of
Eri1 (Sobering et al., 2004). Further evidence for ER signaling comes from studies
in the fission yeast, Schizosaccharomyces pombe (S. pombe). Since S. pombe has
only one Ras protein, Ras1, that regulates two different pathways, it provides a
simple system that can be used to study compartmentalized Ras signaling.

Ras1

controls mating through a Byr2-mitogen-activated protein pathway while maintaining
elongated cell morphology through the Scd1-Cdc42 pathway.

In these studies,

Ras1 mutants were constitutively targeted to the ER/Golgi or the plasma
membrane.

In ras1 null cells, the ER/Golgi restricted Ras1 mutant supported

morphology, but not mating.

On the contrary, the plasma membrane restricted

Ras1 mutant supported mating, but not morphology.

These observations support

the idea that Ras may signal from the ER (Chang and Philips, 2006).
In mammalian cells, the expression of palmitoylated deficient N-Ras or HRas results in cytosolic and endoplasmic reticulum (ER) localized Ras (Choy et al.,
1999). Coexpression of the Ras-GTP fluorescent reporter, GFP-RBD, with
unpalmitoylated H-Ras confirmed that Ras is activated on the ER in response to
epidermal growth factor stimulation. Furthermore, restricting constitutively active H27

Ras to the ER with the transmembrane motif of the avian bronchitis virus M1 protein
to measure signal output reveals poor activation of Erk and Akt pathways (Chiu et
al., 2002). The Ras GEF, RasGRF, is responsible for activation of H-Ras on the
endoplasmic reticulum (Arozarena et al., 2004).
1.7.5 Signaling on the Mitochondria and Nucleus
Another potential signaling platform for Ras is on the mitochondria. The
three main Ras isoforms are present in mitochondrial fractions of an IL-2-dependent
murine T cell line.

Further analysis revealed that Bcl-2 targets K-Ras to the

mitochondria in an IL-2 dependent manner, while mitochondrial Ras does not
require IL-2 (Wang et al., 1996). A recent study has reported that the association of
K-Ras with Bcl-2 is regulated by protein kinase C in Jurkat T cells contributing to
apoptosis (Bivona et al., 2006).

The postulation that Ras may signal from the

mitochondria is intriguing; however, the extensive literature on Ras localization by
microscopy does not report localization on the mitochondria. Moreover, a novel
splice variant of H-Ras, p19, was characterized and is present in the nucleus and
the cytoplasm. Another study revealed that nuclear p19 activates p73 with help
from the MDM2 protein (Mor and Philips, 2006).
1.8 Perspective
In this study, we will investigate the role of single, endogenous Ras isoforms
(H-Ras and K-Ras) on plasma membrane nanodomains and the Golgi.

To

accomplish our aim, we sought to develop tools whereby the signaling of individual
endogenous Ras isoforms can be abolished.

The bulk of the aforementioned

studies have relied on the overexpression of Ras to comprehend Ras function on
the plasma membrane and the Golgi and no isoform-specific anti-Ras tools have
been successfully developed; thus the significance of Ras isoforms on these
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compartments remains unresolved. The establishment of such tools will potentially
increase the understanding of Ras biology.
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Chapter 2. Materials and Methods
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2.1 Chemicals
All chemicals were purchased from Sigma Aldrich unless otherwise stated.
2.2 DNA Constructs
All GFP-GAP-Ras constructs (GFP-GAP, GFP-GAP-CTH, GFP-GAP-CTK,
and GFP-GAP-CTH 181S) were cloned as follows.

For GFP-GAP subcloning,

pEXVkidGAP (Huang et al., 1993) was digested using Sac1 and EcoR1 restriction
enzymes (New England Biolabs). The 1000bp kidGAP fragment was inserted into
Sac1/EcoR1 digested pEGFP-C1.
polymerase (New England Biolabs).

The Sac1 site was removed by T4 DNA
For GFP-GAP-CTH, GFP-GAP-CTK, and

GFP-GAP-CTH 181S cloning, the HVRs of H- and K-Ras were cloned onto the Cterminus of pEGFP-C1-GAP by PCR amplification. This was performed through the
PCR amplification of the CTH, CTK, and CTH 181S sequences from pEGFP-C1CTH, pEGFP-C1-CTK, and pEGFP-C1-CTH 181S with a reverse GFP sequencing
primer (5’CTACAATGGGTATGGC 3’) and the following forward primers: 5’
CCGAATTCAGCACAAGCTGCGGAAGCTGAACC 3’ for pEGFP-C1-GAP-CTH and
pEGFP-C1-GAP-CTH

181S

and

5’

GGGAATTCAGCATAAAGAA

AAGATGAGCAAAGATGG 3’ for pEGFP-C1-GAP-CTK.

Furthermore, the PCR

products were digested with EcoR1/BamH1 and were inserted into EcoR1/BamH1
digested pEGFP-C1-GAP.
2.3 Cell Growth and Maintenance
The following cells were used: BHK, Cos-1, and PC12. All cells were grown
and maintained in 37°C with 5% CO2 injection using Dulbecco’s Modified Eagle
Medium (DMEM) (Hyclone) with additives including 1% sodium pyruvate and
glutamax (Gibco). For PC12 cells, the medium was also supplemented with 10%
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horse serum and 5% fetal bovine serum (FBS). BHK and Cos-1 cells were cultured
in medium containing 10% bovine calf serum (BCSS) and 10% FBS, respectively.
2.4 Cell Transfection and Stimulation
For Ras-GTP pulldown assays, BHK cells were transiently transfected by the
lipofection method with pEGFP, GFP-GAP, GFP-GAP-CTH, GFP-GAP-CTK, or
GFP-GAP-CTH181S using Lipofectamine 2000 reagent (Invitrogen) in 15 cm
dishes. For GFP, GFP-GAP, GFP-GAP-CTH, and GFP-GAP-CTK transfections,
36µg DNA and 40µL Lipofectamine 2000 reagent was used. To achieve optimal
transfection efficiency all dishes were gently shaken for at least 10 times. Cells
were returned to growth medium 3hrs after lipofection.

For GFP-GAP-CTK

transfections, twice as much DNA (72µg) was used and cells were incubated in
transfection mixture for at least 8hrs prior to returning to growth medium.
Approximately 16hrs after transfection, cells were washed twice with Phosphate
Buffered Serum (PBS) (Hyclone) and cells were incubated in serum free medium
(DMEM) for 1hr. Subsequently, the serum-free medium containing 50 ng/ml EGF
was added to cells for the following time points: 2, 5, 10, 20, 40, and 60min.
Immediatley following EGF stimulation for each time period, EGF medium was
removed and cells were washed twice with ice cold PBS. PBS was then replaced
by 1mL Lysis Buffer B (50mM Tris pH 7.5, 75mM NaCl, 25mM NaF, 5mM MgCl2,
5mM EGTA, 0.33 µg/mL aprotinin, 100µM Na3VO4, 3.33 µg/mL leupeptin, 1mM
DTT, and 1% NP40). Cells were incubated in Lysis Buffer B for at least 10min
before removal from dishes using a cell scraper. Cell lysates were transferred into
1.5 mL eppendorf tubes and vortexed. The insoluble material was removed by
centrifugation at 13,000 rpm for 5min and the remaining supernatant stored on ice
for further analysis.
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For Ras signaling experiments, BHK cells were transiently transfected with
Lipofectamine 2000 reagent in 6 cm dishes. For GFP, GFP-GAP-CTH, and GFPGAP-CTH181S transfections, 8µg DNA and 20µL Lipofectamine 2000 reagent was
used. Cells were returned to growth medium 4hrs after lipofection. For GFP-GAP –
CTK transfections, 16µg DNA was used and cells were incubated in transfection
mixture for at least 8hrs prior to returning to growth medium. Approximately 16hrs
after transfection, cells were washed twice with Phosphate Buffered Serum (PBS)
(Hyclone), and cells were incubated in serum free medium (DMEM) for 1hr.
Subsequently, the serum-free medium containing 50 ng/ml EGF was added to cells
for the following time points: 5, 10, 20, 40, and 60min. Immediately following EGF
stimulation for each time period, EGF medium was removed and cells were washed
twice with ice cold PBS. PBS was then replaced by 150µL Lysis Buffer B. Cells
were incubated in Lysis Buffer B for at least 10min before removal from dishes
using a cell scraper and cell lysates were prepared as described above.
For confocal microscopy studies, BHK cells were treated the same as Ras
signaling experiments; however cells were transfected on coverslips in 6 well plates
and fixed instead of harvested. See Confocal Microscopy for fixation conditions.
PC12 cells were transiently transfected on coverslips by the lipofection method with
pEGFP, GFP-GAP-CTH, GFP-GAP-CTK, or GFP-GAP-CTH181S GFP using
Lipofectamine 2000 (Invitrogen) in 6 well plates. PC12 cells were transfected using
the same conditions as the Ras signaling experiments.

Three hours after

lipofection, the cells were returned to growth medium. Approximately 24hrs after
transfection, cells were washed twice with PBS and fresh growth medium containing
100 ng/ml NGF was added. Cells were placed in a CO2 incubator at 37°C for an
additional 72hrs to assess neurite outgrowth under a confocal microscope.
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2.5 Bradford Assay
Following cell harvesting with Lysis Buffer B, the protein concentration for
each sample was determined. Samples were centrifuged at 13,000 rpm for 5 min.
The pellet was discarded and the supernatant was sonicated for homogenization.
BSA protein standards ranging from 200-1000 ng/µL were used. Samples were
diluted as needed and were analyzed in triplicates by pipetting 5µL of sample into a
96

well

plate.

The

spectrophotometer.

absorbance

was

measured

at

595

nm

using

a

The protein concentration of the unknown sample was

determined from a graph of the standard curve of ng of BSA verses the absorbance.
2.6 Western Blot Analysis
Proteins were separated on 12% SDS-PAGE. Electrophoretic transfer onto
polyvinlyidene fluoride (PVDF) membrane was performed at 25 volts for 30min.
using a semidry transfer apparatus (Model: Trans-Blot SD Cell, Bio-Ras). After the
transfer, blots were stained with Commassie Blue to evaluate transfer efficiency.
Membranes were incubated for 1hr at room temperature in blocking buffer (5% dry
non-fat milk in 1X TBS (20mM Tris, 137mM NaCl, pH 7.6 with HCL) and 0.1%
Tween-20 for non-phospho-blots; 3% BSA in 1X TBS and 0.1% Tween-20 for
phosphor-blots.

Membranes were subsequently probed with primary antibodies

diluted in the appropriate blocking buffer for 2hrs at room temperature.

The

membranes were washed 3 times for 5min with a washing buffer (1X TBS, 0.1%
Tween-20), and then incubated in the appropriate secondary antibody for 1hr at
room temperature. All antibody incubations were performed on a shaker. Following
antibody incubations, the membranes were treated with chemiluminescence
detection reagents (SuperSignal West Dura Stable Peroxide/ Luminal-Enhancer

34

Solutions or SuperSignal West Stable Peroxide/Luminal-Enhancer Solutions,
Thermo Scientific and analyzed by quantifying each lane using the FluorChem Q.
2.7 Antibodies used for Western Blotting
The following antibodies were from Cell Signaling: phosphor-Akt (Ser473),
rabbit monoclonal antibody; Akt (pan), mouse monoclonal antibody; p44/42 MAPK
(ERK ½), rabbit monoclonal antibody; HA-tag, and mouse monoclonal antibody.
ERK2 and H-Ras rabbit polyclonal antibodies were from Santa Cruz Biotechnology.
Anti-GFP and Anti-K-Ras mouse monoclonal antibodies were form Sigma. Anti-Ras
(mouse monoclonal antibody) was from BD Transduction Laboratories. Goat antimouse and anti-rabbit antibodies were from Invitrogen.
2.8 Confocal Microscopy
BHK and Cos-1 cells were transfected on coverslips.

PC12 cells were

transfected on coverslips that were previously coated with poly-L-lysine. Cells were
washed 3 times with PBS and fixed with 4% paraformaldehyde/PBS solution for 30
min at room temperature followed by washing steps with PBS and water.
Coverslips were mounted on slides in Mowiol for confocal microscopy. Slides were
allowed to dry for at least 1hr at 37°C prior to use of the A1 Nikon Confocal
Microscope.
2.9 Golgi Staining
BHK cells were transfected on coverslips as previously described. The day
after transfection, cells were exposed to the components of the Organelle LightsTM
Intracellular Targeted Green Fluorescent Proteins kit (Contents: Organelle Lights
reagent, BacMam enhancer, Dimethylsulfoxide (DMSO), Invitrogen) The Organelle
Lights reagent consists of a baculovirus which is responsible for directing the
expression of autofluorescent proteins (in this case the Golgi resident enzyme, N35

acetylgalactosominyltransferase 2) to a specific subcellular location. The growth
medium was replaced with diluted Organelle Lights reagent (Component A) as
explained in the manufacturer’s instructions. Cells were allowed to incubate for
2hrs with gentle rotation at room temperature. Following incubation, the reagent
was replaced with growth medium containing diluted enhancer (Component B and
C) and cells were placed in the incubator for 2hrs. Finally, cells were fixed as stated
before in preparation for observation of Golgi staining by confocal microscopy.
2.10 GST-RBD (Ras Binding Domain of Raf-1) Pull-down Assay
2.10.1 Expression of GST-RBD in bacteria
For GST-RBD expression, 50 ml of Luria broth (L-broth) supplemented with
100 ug/ml of ampicillin was inoculated with plasmid name here GST-RBD K85A
glycerol stock and incubated overnight at 37°C with constant agitation. The 50ml
culture was then added to 2L of L-broth containing 100 µg/ml ampicilin and
incubated at 37°C with agitation for approximately 4hrs or until the culture reached
an OD600 value of 0.6. After incubation, 0.2 mM IPTG was added to the culture with
subsequent incubation for another 4hrs under the same conditions. The bacterial
cells were pelleted by centrifugation at 6000 rpm for 15min at 4°C.
2.10.2 Purification and Storage of GST-RBD
For purification of GST-RBD, the bacterial cells above were resuspended in
30ml STE buffer (10 mM Tris (pH 8.0 with HCl), 150 mM NaCl, 1 mM EDTA,
100µg/ml lysozyme, and 1 mM PMSF). The suspension was incubated at 4°C on a
rotator. Following incubation, 5 mM DTT and 1.5% N-Laurylsarcosine sodium salt
(prepared in STE buffer) was added to the suspension. The cells were shaken
vigorously and sonicated on ice for 1min at the maximal power level using the name
here. The cells were thoroughly mixed with 3% Triton X-100 (prepared in STE
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buffer) and incubated on ice for 30min. After incubation, cells were sonicated as
previously described. Insoluble material was pelleted by centrifugation at 13,000
rpm for 20min at 4°C. The supernatant was mixed with 4ml of a 50% suspension of
glutathione agarose beads (Sigma Aldrich) overnight on a rotator at 4°C. Following
overnight incubation, the beads were washed 6 times for 10min in a mixture of PBS
and 0.1% Triton X-100. The beads were resuspended in 4ml of storage buffer (50
mM Hepes (pH 7.4 with HCl), 150 mM NaCl, 5 mM DTT and 10% sterile glycerol)
as a 50% suspension. The beads were checked for the bound fusion protein, GSTRBD, by SDS-PAGE gel. Aproximately 20µl of GST-RBD beads (50% suspension)
and 5µl of 5X sample buffer were loaded onto a 12% gel after being boiled at 95°C
for 5min. The gel was stained with Coomassie Blue for approximately 5min and
washed 3 times for 3min with destaining solution (10% acetic acid, 50% methanol)
to view the GST-RBD fusion protein band. Finally, the beads were stored for future
use as aliquots that were snap frozen on dry ice and stored at -80°C.
2.10.3 Ras GTP Pull-down Assay
After each time point of EGF addition, cells were immediatedly placed on ice
followed by 2 washes with ice-cold PBS. The PBS was removed and cells were
harvested in 1ml of ice-cold lysis buffer with a cell scraper. Insoluble material was
pelleted by centrifugation at 13,000 rpm for 5min.

The pelleted material was

discarded, and the protein concentration of the supernatant was determined by the
Bradford Assay. A total of 1mg of protein was used for the pulldown assay and
20µg of protein was set aside for immunoblotting to determine protein input. For the
pulldown assay, the protein was combined with 1ml of binding buffer (50 mM Tris
pH 7.5, 10 mM MgCl2, 0.5 mg/ml BSA, 0.5 mM DTT, 100mM NaCl) and 20µl of
GST-RBD beads described previously. The new protein mixture was allowed to
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incubate on a rotator overnight at 4°C. The following day, the mixture was spun
down at 13000 rpm for 1min to separate the beads from the buffer.

The

supernatant was removed and replaced with 1ml of binding buffer and placed on the
rotator for 5 minutes. This washing procedure was repeated for 2 more times with
the final step of separating the beads from the buffer by centrifugation as described
previously. The supernatant was removed and discarded. The beads were mixed
with 5µl of 5x sample buffer and were boiled at 95°C for 5min in preparation for
immunoblotting against Ras proteins.
2.12 Proliferation Assay
BHK cells transiently transfected with GFP-tH or GFP-GAP-Ras constructs
were analyzed by FACS (BDFortessa). Prior to FACS analysis, BHK cells were
transiently transfected using the same conditions as Ras signaling experiments.
Cells were plated in 24 well plates in triplicates. Each day cells were harvested
using trypsin/EDTA solution. The number of GFP expressing cells was quantified
and recorded for each day.
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Chapter 3. Results
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3.1 Introduction
It is unclear how individual endogenous Ras isoforms function on plasma
membrane nanodomains and the Golgi in cells.

Multiple strategies have been

utilized in an attempt to reveal the functions of each Ras isoform. K-Ras null cells
were used to determine the role of K-Ras. However, these cells do not express
both K-Ras4B and K-Ras4A, making the effects of K-Ras4B difficult to isolate. RNA
interference had also been used but failed to equally down-regulate all Ras isoforms
(Khanzada et al., 2006).

Dominant negative mutants of Ras isoforms are also

inadequate as they fail to act specifically on one endogenous Ras isoform
(Matallanas et al., 2003). Moreover, all the above studies do not acknowledge the
localization of Ras proteins to the Golgi making it difficult to differentiate between
Ras isoform-specific signaling from the plasma membrane and the Golgi. Tools that
will allow us to specifically target endogenous Ras proteins on these compartments
are needed to effectively determine the role of endogenous Ras isoform-specific
signaling.
Ras signaling from the Golgi is a controversial topic as not all investigations
have been able to demonstrate Golgi-localized Ras activity.

Nevertheless, at

steady state, palmitoylated Ras isoforms such as H-Ras are present on the plasma
membrane as well as the Golgi, and furthermore, 2 models for Ras activation on the
Golgi have been previously described. In the first model, described in T cells, Ras
activation occurs directly on the Golgi where Ras is activated by Src-dependent
activation of phospholipase C-γ1 (PLC-γ1) resulting in an increase in diacylglycerol
(DAG) and the subsequent translocation of the RasGEF RasGRP1 from the cytosol
to the Golgi.

RasGRP1 can also activate Ras on the plasma membrane in

response to co-stimulation by the T cell receptor and the integrin LFA-1. Another
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model suggests active Ras-GTP on the Golgi is derived from the plasma membrane
due to a rapid and continuous depalmitoylation/re-palmitoylation cycle that occurs
after posttranslational modifications of the Ras C-terminus.

Either way, recent

reports indicate that Ras signaling from the Golgi is important. Studies in yeast
reveal that Ras signaling from the endomembrane controls morphology, while Ras
signaling from the plasma membrane regulates mating. In mammalian cells, the
kinetics of Ras activation on the Golgi are different from the plasma membrane as
well as the kinetics of ERK output.

In thymocyte selection, endogenous Ras

signaling from the Golgi is essential for positive selection, whereas Ras signaling
from the plasma membrane is required for negative selection. However, whether or
not Golgi activation of endogenous Ras has physiological relevance is still largely
unknown.
Here, we design novel tools to target endogenous H-Ras or K-Ras isoforms
and abrogate Ras signaling on the compartments mentioned above.

A critical

component for the localization of Ras to various compartments in the cell is the
hypervariable region (HVR) which encodes the membrane anchors and the
adjacent sequences required for membrane targeting (Hancock, 2003). Predicated
on this vital role of the HVR, we hypothesize that, when fused to GAP, the HVR of
Ras isoforms will target GAP to Ras nanoclusters on the plasma membrane and to
the Golgi and selectively inhibit endogenous Ras activity. Specifically, we aim to
demonstrate that each targeted GAP construct will correctly confine to areas where
the cognate Ras isoform is present. This is important, because it alludes to their
ability to abrogate specific Ras isoform activation on the plasma membrane and the
Golgi.

Next, we will investigate the ability of each targeted GAP construct to

abrogate the activation of endogenous Ras isoforms and the specificity of these
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GAP constructs on the corresponding Ras isoform. The inhibition of endogenous
Ras isoforms will allow us to investigate the function of Ras isoform-specific
signaling on two separate compartments of the cell, an approach which has never
been done. This will include an investigation of the ability of Ras isoform-specific
inhibitors to abrogate Ras signal transduction. We are particularly interested in two
Ras dependent signaling pathways, Raf/MEK/ERK and PI3-K/Akt, because these
pathways are the only Ras effector pathways that are also commonly mutated in
human cancer (De Luca et al., 2012). Finally, we will examine the physiological
relevance of Ras signaling from the plasma membrane and the Golgi. Our findings
may provide new insights into Ras function.
3.2 Results
3.2.1 The HVR Targets GFP-RasGAP to the Plasma Membrane and Golgi
In an effort to create proteins that specifically inhibit GTP-loaded H-Ras and
K-Ras on plasma membrane nanodomains and on the Golgi, we constructed GAP
molecules that are targeted to specific sub-cellular compartments. First, we subcloned the catalytic GAP domain (amino acids 701-1044) of p120RasGAP (Huang
et al., 1993) onto the C-terminus of GFP in the enhanced green fluorescent protein
plasmid, pEGFP. As depicted in Figure 3.1, full-length p120RasGAP has only one
region, the catalytic GAP domain, which interacts with GTP-bound Ras and thus is
responsible for hydrolyzing GTP to GDP, converting active Ras to inactive Ras
(Mitin et al., 2005).
Secondly, we cloned the complete carboxyl HVRs of H-Ras (amino acids
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Figure 3.1 Full-length p120RasGAP.
p120RasGAP and their known functions.

Schematic illustrating the domains of

166-189) or K-Ras (amino acids 166-188) by PCR amplification onto the C-terminus
of pEGFP-GAP. The HVR or the C-terminus of H-Ras or K-Ras (CTH or CTK) is
necessary and sufficient for its membrane targeting. Previous work has shown that
GFP-CTH and GFP-CTK undergo the same trafficking pathway as full length H-Ras
and K-Ras, respectively (Apolloni et al., 2000).

Figure 3.2. Schematic representation of Ras and nomenclature of regions.
Illustration of full-length Ras isoforms and the extreme C-terminal domain called the
hypervariable region (HVR). The HVR is divided into two parts: the linker and
membrane anchor domains. The C-terminal HVR of H-Ras (residues 166-189) is
denoted by CTH or CTH181S and the HVR of K-Ras (residues 166-188) is denoted
by CTK.
Additionally, these HVRs target exogenous proteins to specific plasma membrane
nanodomains that co-localize with the corresponding GTP-loaded Ras isoform
(Inder et al., 2008). Finally, we created a third construct by introducing a point
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mutation in the HVR of H-Ras at position C181, changing the cysteine to serine as
previously described (Inder et al., 2008).

The 181S mutation disables forward

trafficking to the plasma membrane causing the protein to remain in the Golgi (Roy
et al., 2005). Illustrated in Figure 3.2 are the C-terminal HVRs of H-Ras or K-Ras
mentioned above. The organization of these GFP-RasGAP proteins is displayed in
Figure 3.3. We predict that GFP-GAP-CTK will localize exclusively to the plasma
membrane, while GFP-GAP-CTH will localize predominantly to the plasma
membrane and partially to the Golgi.

GFP-GAP- CTH181S will localize almost

exclusively to the Golgi.

Figure 3.3. GFP-RasGAP proteins. Schematic demonstrating the organization of
GFP-RasGAP proteins.

To validate the localization of RasGAP proteins, each protein was transiently
expressed into Baby Hamster Kidney (BHK) cells and the localization visualized in
fixed cells by fluorescence microscopy. Figure 3.4 shows that the controls, GFP
and GFP-GAP, did not localize to any membrane, but instead decorated the cytosol
and nucleoplasm. For detection of the Golgi, cells expressing GFP-GAP-CTH and
GFP-GAP-CTH181S

were

stained

with

a

RFP-Golgi

acetylgalactosaminyltransferase-2) prior to fixation and imaging.

marker

(N-

As expected,

GFP-GAP-CTK exclusively localized to the plasma membrane like K-Ras. GFPGAP-CTH predominantly localized to the plasma membrane, but with some degree
of intracellular staining. GFP-GAP-CTH181S co-localized with the RFP-Golgi
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Figure 3.4. The HVR targets GFP-RasGAP to the Plasma Membrane and Golgi.
BHK cells transiently expressing GFP-RasGAP proteins were stained with a RFPGolgi marker followed by fixation on coverslips. The sub-cellular localization of
each GFP-RasGAP protein was visualized by fluorescence microscopy.
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marker, indicating the presence of a Golgi pool, although a very small amount of the
GFP-RasGAP protein was also present on the plasma membrane. Taken together,
these observations revealed that the membrane distributions of GFP-RasGAP
proteins were directed by the HVR of H-Ras or K-Ras and may co-localize with fulllength Ras proteins.

Therefore, the cellular localization of each GFP-RasGAP

protein was as predicted, demonstrating their potential to specifically abrogate
individual endogenous GTP-loaded Ras isoforms.

Figure 3.5. Equivalent Expression of GFP-RasGAP Proteins. Wild-type BHK
cells and BHK cells transiently expressing GFP-RasGAP proteins were analyzed by
immunoblot using anti-GFP antibody for equivalent expression. This blot serves as
a representative blot for all GFP-RasGAP transfections.
3.2.2 GFP-RasGAP Proteins Specifically Inhibit Endogenous Ras Isoforms
We next examined the ability of GFP-RasGAP proteins to specifically
abrogate activation of individual endogenous Ras isoforms. Therefore, we prepared
whole cell lysates (WCLs) from BHK cells and BHK cells transiently expressing
GFP-RasGAP proteins. These were then immunoblotted with anti-GFP (Figure 3.5)
to confirm equivalent expression of GFP-RasGAP proteins.

To observe Ras

activation in response to a specific growth factor, quiescent BHK cells transfected
with GFP-RasGAP constructs were stimulated with a saturating dose of EGF (50
ng/mL) at various times ranging from 2 to 60min.

Following stimulation,

endogenous GTP-bound Ras proteins were isolated by GST-RBD pull-down and
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the levels of GTP-bound Ras were detected by immunoblotting with a pan-Ras, HRas, or K-Ras antibody.

As demonstrated in Figure 3.6, the kinetics of Ras

activation in control cells (Empty Vector) show maximal levels of GTP-loaded Ras
proteins (H-Ras, K-Ras, and N-Ras) occurring rapidly at 2 min. followed by a return
to basal levels around 60min. Cytosolic GAP or GFP-GAP did not have any effect
on total GTP-loaded Ras levels. This was expected since GFP-GAP did not occupy
any membrane structure in BHK cells as visualized by fluorescence microscopy;
thus, displaying the importance of the HVR for targeting exogenous proteins to the
membrane. However, cells that expressed GFP-GAP-CTK (Figure 3.7) or GFPGAP-CTH (Figure 3.8) specifically inhibited endogenous GTP-loaded K-Ras or HRas, respectively. Significant inhibition was observed at the early times assayed (210min). Neither construct had an inhibitory effect on the Ras isoform that was not

Figure 3.6. Cytosolic GAP Does Not Inhibit Ras Activation. BHK cells
transiently expressing GFP (Empty Vector) and GFP-Cytosolic GAP proteins were
serum starved for 1 hr. and stimulated with 50ng/ml EGF for time points up to 60
min. A) GTP-loaded Ras proteins were isolated by GST-RBD pull-down and
detected by immunoblot using pan-Ras antibody. Whole cell lysates (WCL) were
imunoblotted using pan-Ras antibody for protein input. B) Blots were quantified and
the graph show the levels of GTP-Ras at each time point normalized to GFP time
point 0 (means ± SEM, n=3)
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***
*** ***

Figure 3.7. GFP-GAP-CTK abrogates endogenous K-Ras Activation. BHK cells
transiently expressing GFP (Empty Vector) and GFP-GAP-CTK proteins were
serum starved for 1 hr. and stimulated with 50 ng/ml EGF for time points up to 60
min. A) C) GTP-loaded Ras proteins were isolated by GST-RBD pull-down and
detected by immunoblot using H-Ras or K-Ras antibody. Whole cell lysates (WCL)
were imunoblotted using pan-Ras antibody for protein input. B) D) Blots were
quantified and the graph shows the levels of GTP-Ras at each time point
normalized to GFP time point 0 (means ± SEM, n=4)
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Figure 3.8. GFP-GAP-CTH abrogates endogenous H-Ras Activation. BHK cells
transiently expressing GFP (Empty Vector) and GFP-GAP-CTH proteins were
serum starved for 1 hr. and stimulated with 50 ng/ml EGF for time points up to 60
min. A) C) GTP-loaded Ras isoforms were isolated by GST-RBD pull-down and
detected by immunoblot using H-Ras or K-Ras antibody. Whole cell lysates (WCL)
were imunoblotted using pan-Ras antibody for protein input. B) D) Blots were
quantified and the graph shows the levels of GTP-Ras at each time point
normalized to GFP time point 0 (means ± SEM, n=4)
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Figure 3.9. GFP-GAP-CTH181S Effects on Ras Activation. BHK cells transiently
expressing GFP (Empty Vector) and GFP-GAP-CTH181S proteins were serum
starved for 1 hr. and stimulated with 50 ng/ml EGF for time points up to 60 min. A)
C) GTP-loaded Ras isoforms were isolated by GST-RBD pull-down and detected by
immunoblot using H-Ras or K-Ras antibody. Whole cell lysates (WCL) were
imunoblotted using pan-Ras antibody for protein input. B) D) Blots were quantified
and the graph shows the levels of GTP-Ras at each time point normalized to GFP
time point 0 (means ± SEM, n=4)
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associated with its targeted domain. Therefore, GFP-GAP-CTK had no effect on
H-Ras activation, and GFP-GAP-CTH had no effect on K-Ras activation.
Unexpectedly, we did not detect any effect of the Golgi localized GFP-RasGAP
protein, GFP-GAP-CTH181S, on Ras activation. As depicted in Figure 3.9, there
are relatively low levels of GTP-Ras at the late time points (20-60 min) when Golgi
Ras activation is maximal. Our method may, therefore, not be sufficiently sensitive
to detect changes in this low level of Ras activation.

However, there was no

abrogation at the earlier times (2-10min) by GFP-GAP-CTH181S where Ras is
maximally activated.

Since Ras activation on the plasma membrane has been

previously shown to occur between 2-10min following EGF stimulation, we can
conclude that very little GFP-GAP-CTH181S has access to GTP-Ras generated on
the plasma membrane.
3.2.3 GFP-RasGAP Proteins Specifically Inhibit Ras Isoforms on the PM and Golgi
In an effort to resolve the sensitivity issue of the GST-RBD pull-down assay
and verify the ability of the targeted GAP proteins to specifically abrogate activation
of

Ras isoforms in distinct sub-cellular compartments we used confocal

microscopy. The Ras binding domain (RBD) C-Raf (amino acids 51-131) has been
previously used in imaging studies to report where and when Ras is active in cells
(Walker and Lockyer, 2004). We therefore generated an RFP-RBD fusion protein
by cloning RFP onto the N- terminus of the RBD. We then tested the ability of this
fluorescent probe (RFP-RBD) to detect Ras activation on the plasma membrane
and Golgi in fixed cells. As shown in Figure 3.10, expression of RFP-RBD alone in
Cos-1 cells resulted in a homogenous localization to the cytosol and nucleoplasm
with no evidence of membrane decoration.
constitutively active form of
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However, in the presence of a

Figure 3.10. RFP-RBD Detects GTP-Loaded Ras on the Plasma Membrane and
the Golgi. Cos-1 cells were transiently transfected with RFP-RBD or RFP-RBD
and GFP-HrasG12V. Cells were fixed on glass coverslips and visualized by
fluorescence microscopy.
H-Ras, H-RasG12V, the RFP-RBD probe was recruited to both the plasma
membrane and Golgi, co- localizing exclusively with active H-Ras. Next, RFP-RBD
was transiently co- expressed with GFP-RasGAP proteins in the presence or
absence of wild-type H- Ras or K-Ras.

Cells were deprived of serum prior to

stimulation with EGF for 2min in order to observe maximal EGF-induced Ras
activation on the plasma membrane. The extent of RFP-RBD localization to the
plasma membrane was quantified using Image J software and the fraction of RFPRBD recruitment to the plasma membrane was calculated (Figure 3.11). As shown
in Figure 3.12, in response to EGF stimulation, most of RFP-RBD is localized to the
cytosol.

When RFP-RBD was co-expressed with H-Ras or K-Ras, a dramatic

redistribution of RFP-RBD from the cytosol to the plasma membrane was observed
upon EGF stimulation. In cells expressing wild-type K-Ras, the presence of GFPGAP-CTK significantly reduced recruitment of RFP-RBD to the plasma membrane.
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Figure 3.11. Quantification of RFP-RBD Localization to the Plasma Membrane.
In GFP-RasGAP expressing cells, the extent of RFP-RBD localization to the plasma
membrane (PM) was determined via quantification by Image J software. A line
scan was drawn manually across individual healthy cells for quantification of RFPRBD localization. The output generated is a plot of the intensity values of RFP-RBD
From the plot, areas representing RFP-RBD intensity on the PM or the cytosol
(CYT) were identified and gated as shown. RFP-RBD intensity values for the PM
were integrated and the average determined. RFP-RBD intensity values for the
CYT were also averaged. The percentage of PM-recruited RFP-RBD, was
calculated by a ratio of the average RFP-RBD intensity values
on the PM and
the sum of the averages of RFP-RBD intensity values on the PM and the CYT. This
was done for each cell.

Figure 3.12. GFP-RasGAP Proteins Abrogate Ras Activation on the Plasma
Membrane. Cos-1 cells were transiently transfected with GFP-RasGAP proteins
and/or RFP-RBD in the presence or absence of wild-type Ras. Cells were serum
starved and stimulated with 50 ng/ml EGF for 2min and subsequently fixed and
visualized by fluorescence microscopy. The average RFP-RBD intensity on the
plasma membrane was determined by Image J software. A)The graph represents 3
individual experiments with means ± SEM, n=100. B) Respresentative blots
demonstrating the expression of each construct.
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GFP-GAP-CTK did not affect H-Ras mediated recruitment of RFP-RBD to the
plasma membrane. Similarly, GFP-GAP-CTH expression abrogated recruitment of
RFP-RBD to the plasma membrane in cells expressing H-Ras, but not K-Ras. To
observe Ras activation on the Golgi, we co-expressed RFP-RBD with CFP-H-Ras
and GFP-RasGAP proteins and imaged cells after 40min of EGF stimulation.
Expression of CFP-H-Ras permits visualization of Ras on the Golgi. The extent of
RFP-RBD localization to the Golgi was determined only from cells where Golgi
staining by CFP-H-Ras was evident using Image J software. Hereafter, we
assessed the fraction of RFP-RBD recruitment to the Golgi (Figure 3.13).

Figure 3.13. Quantification of RFP-RBD Localization to the Golgi. In GFPRasGAP expressing cells, the extent of RFP-RBD localization to the Golgi was
determined via quantification by Image J software. A line scan was drawn manually
across individual healthy cells for quantification of RFP-RBD or CFP-H-Ras
localization. The output generated is a plot of the intensity values of RFP-RBD or
CFP-H-Ras. From the CFP-H-Ras line scan, the Golgi was identified. Then, the
areas representing CFP-H-Ras intensity on the Golgi were identified and gated.
These marked boundaries were also used to identify and gate RFP-RBD
recruitment to the Golgi on the RFP-RBD plot. CFP-H-Ras and RFP-RBD intensity
intensityvalues for the Golgi were averaged. A ratio of Golgi-recruited RFP-RBD
and Golgi-recruited CFP-H-Ras was determined. This was done for each cell.
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As shown in Figure 3.14, a significant portion of RFP-RBD accumulation on the
Golgi is clearly visible after 40 min. of EGF stimulation when wild-type H-Ras is
expressed. Figure 3.15 shows that GFP-GAP-CTH did not affect the recruitment of
RFP-RBD to the Golgi; however, GFP-GAP-CTH181S expression caused
significant reduction of RFP-RBD localization to the Golgi. These data support the

Figure 3.14. RFP-RBD Colocalizes with CFP-H-Ras. Cos-1 cells were transiently
transfected with RFP-RBD or RFP-RBD and CFP-Hras WT and stimulated with 50
ng/ml EGF for 40 min. Immediately following stimulation, cells were fixed on glass
coverslips and visualized by fluorescence microscopy.
previous findings that all 3 GFP-RasGAP targeted proteins specifically abrogate
activation of specific Ras isoforms, which occurs on the plasma membrane and the
Golgi.
3.2.4 Effects of GFP-RasGAP Proteins on Ras Signal Transduction
In order to investigate the ability of GFP-RasGAP proteins to abrogate Ras
signal transduction, we assayed the effects of GFP-RasGAP on the MAPK and PI3K/Akt signaling pathways. GFP-RasGAP proteins were transiently expressed in
BHK cells that were serum starved and stimulated with EGF for various times
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Figure 3.15. GFP-GAP-CTH181S Abrogates Ras Activation on the Golgi. Cos-1
cells were transiently transfected with GFP-RasGAP proteins and/or RFP-RBD in
the presence or absence of CFP-H-Ras. Cells were serum starved for 1 hr. and
stimulated with 50ng/ml EGF for 40min and subsequently fixed and visualized by
fluorescence microscopy. The average RFP-RBD intensity on the Golgi was
determined by Image J software. A) The graph represents 3 individual experiments
with means ± SEM, n=100. B) Respresentative blots demonstrating the expression
of each construct.
immunoblotting whole cell lystates using antiserum against ppERK and pAkt. As
seen in Figure 3.16, maximal ERK activation occurs at 10min of growth factor
stimulation and subsequently reduces, but does not return to basal levels on the
time cap of this experiment.

Figure 3.16 shows that GAP-CTK significantly

decreased the level of ppERK when ERK was maximally activated (10min). GFPGAP-CTH had no significant effect on the level of EGF-stimulated ppERK compared
to the control cells (Empty Vector). Similarly, GFP-GAP-CTH181S did not alter the
ERK activation profile. EGF-induced activation of Akt differs from ERK activation.
Figure 3.17 shows that the activation profile of Akt has two peaks, one at 5min and
the other at 40min following growth factor stimulation.

Intriguingly, GFP-GAP-

CTH181S significantly increased Akt activation at 5min; however GFP-GAP-CTH
and GFP-GAP-CTK had no effect on the activation profile of Akt. Since ERK
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Figure 3.16. EGF stimulation of the MAPK pathway is significantly inhibited by
GFP-GAP-CTK. BHK cells transiently expressing GFP (Empty Vector) and A)
GFP-GAP-CTH, B) GFP-GAP-CTK, and C) GFP-GAP-CTH181S were serum
starved for 1 hr. and stimulated with 50 ng/ml EGF for times up to 60 min. Whole
cell lysates were analyzd by immunoblotting with a ppERK antibody or pan-ERK.
Blots were quantified and the graph shows the levels of ppERK at each time point
normalized to GFP time point 0 (means ± SEM, n≥7).
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Figure 3.17. GFP-RasGAP Proteins Effect on the Akt Pathway. BHK cells
transiently expressing GFP (Empty Vector) and A) GFP-GAP-CTH, B) GFP-GAPCTK, and C) GFP-GAP-CTH181S were serum starved for 1hr. and stimulated with
50 ng/ml EGF for times up to 60 min. Whole cell lysates were analyzed by
immunoblotting with a pAKt473 antibody or pan-Akt. Blots were quantified and the
graphs show the levels of pAkt473 at each time point normalized to GFP time point
0 (means ± SEM, n≥9).
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activation is exclusively inhibited by GFP-GAP-CTK, we can conclude that EGF
stimulation of the Raf/MEK/ERK pathway is predominantly mediated by K-Ras,
whereas activation of thePI3-K/Akt pathway appears largely Ras independent.
3.2.5 Effects of GFP-RasGAP Proteins on Ras-Dependent Biological
Next, we examined the biological consequences of inhibiting endogenous
Ras signaling by assaying cellular proliferation and differentiation.
assayed cellular growth and viability via flow cytometry.

First, we

BHK cells transiently

transfected with GFP-RasGAP constructs were grown in culture over a period of 4
days and the number of GFP expressing cells in a total cell population of 10,000
cells was quantified each day using flow cytometry. As a control, we used GFP
tagged to the minimal targeting motif of H-Ras, GFP-tH.

GFP-tH has been

characterized as a plasma membrane marker. In this assay, if the expression of
GFP-RasGAP proteins inhibits cellular growth, proliferation, or viability, the number
of GFP positive cells will decrease while non-transfected cells continue to grow and
eventually take over the cell population.

As demonstrated in Figure 3.18,

expression of GFP-tH had no significant effect on the fraction of GFP-expressing
cells present throughout the 4 day period indicating that expression of GFP-tH does
not compromise cellular growth or viability. However, expression of GFP-RasGAP
proteins resulted in a significant decrease in the number of GFP positive cells
during the time assayed.

GFP-GAP-CTK and GFP-GAP-CTH were equipotent

inhibitors of cellular growth and viability, whereas GFP-GAP-CTH181S was less
potent.

Next, we examined the effect of GFP-RasGAP protein expression on

cellular differentiation using a PC-12 differentiation assay.

Rat adrenal

pheochromocytoma (PC-12) cells are widely utilized as a model system for
neuronal differentiation since they stop dividing and terminally differentiate in
59

response to nerve growth factor (NGF) (Santos et al., 2007). Figure 3.19 shows an
undifferentiated PC-12 cell and an example of a differentiated PC-12 cell. In this
section of the study, we transiently transfected PC-12 cells with or without

Figure 3.18. Effects of GFP-RasGAP Proteins on Cellular Proliferation. BHK
cells were transiently transfected with GFP-tH, GFP-GAP-CTH, GFP-GAP-CTK, or
GFP-GAP-CTH181S in triplicates. The number of GFP-positive cells was quantified
each day by a flow cytometer over a period of 4 days. The graph shows the relative
number of GFP-positive cells for the indicated constructs normalized to Day 1 of
GFP-tH (means ± SEM, n=3).
GFP-RasGAP proteins and stimulated these cells with 100 ng/mL NGF. Then, we
imaged and counted undifferentiated and differentiated transfected cells. Cells with
neurite outgrowths equal to or more than twice the size of the cell body were
counted as differentiated, while cells with shorter or no neurite outgrowths were
considered undifferentiated.

Expression of GFP-RasGAP proteins significantly

decreased differentiation of PC-12 cells (Figure 3.18). Specifically, GFP-GAP-CTK
and GFP-GAP-CTH suppressed differentiation with similar potency, while GFPGAP-CTH181S suppressed differentiation with greater efficiency than GFP-GAPCTK and GFP-GAP-CTH. Since differentiation of PC-12 cells is greatly attenuated
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by the expression of GAP targeted to the Golgi (GFP-GAP-CTH181S), we can
conclude that Ras activation on the Golgi is a major driver of cellular differentiation.
On the contrary, GFP-GAP-CTK and GFP-GAP-CTH, but not GFP-GAP-CTH181S,
are more potent attenuators of cellular growth of BHK cells; thus Ras activation on
the plasma membrane is the major driver of cellular proliferation.

Figure 3.19. Effects of GFP-RasGAP Proteins on Cellular Differentiation. PC12 cells were transiently transfected with GFP (Empty Vector), GFP-GAP-CTH,
GFP-GAP-CTK, or GFP-GAP-CTH181S and assayed for differentiation after 72 hrs
of stimulation by NGF. A) The graph shows the mean (± SEM, n=100) percentage
of transfected, GFP-positive cells with neurite outgrowths equal to or more than
twice the size of the cell body. Data represents 3 individual experiments. B)
Representative images of differentiated and undifferentiated cells counted.
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Chapter 4. Discussion
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4.1 Introduction
There is clear evidence that Ras proteins can be activated on multiple
cellular compartments in addition to the plasma membrane. The significance of Ras
signaling from the endomembrane, however, is unclear.

To address this, we

constructed Ras isoform-specific inhibitors, GFP-RasGAP fusion proteins, targeted
to distinct plasma membrane nanodomains and the Golgi. We found that each
GFP-RasGAP protein specifically abrogates the targeted endogenous Ras isoform
on the plasma membrane and Golgi. We observed striking differences in the ability
of GFP-RasGAP proteins to inhibit Ras signal transduction. Furthermore, we found
that the expression of GFP-RasGAP proteins significantly and differentially altered
the biological output of Ras signaling.
4.2 Role of Endogenous Ras Signaling
By abrogating the activity of an individual, endogenous Ras isoform with the
corresponding GFP-RasGAP protein, novel insight into the organization of
endogenous Ras proteins on the nanoscale level was discovered.

We

demonstrated that endogenous GTP-bound H-Ras and K-Ras occupy distinct
plasma membrane nanodomains.

This supports previous data which used

ectopically expressed Ras proteins to show differential nano-localization of each
Ras isoform on the plasma membrane (Murakoshi et al., 2004; Plowman et al.,
2005; Prior et al., 2003; Roy et al., 2005).
Since one function of Ras nanoclusters in Ras signaling is to recruit C-Raf to
the plasma membrane for subsequent activation (Harding and Hancock, 2008a;
Harding and Hancock, 2008b; Tian et al., 2007), we were able to investigate the
role of endogenous Ras proteins in C-Raf activation in plasma membrane
nanodomains. We demonstrated that GFP-RasGAP targeted by the HVR of K-Ras
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but not the HVR of H-Ras significantly attenuated the levels of activated ERK in
response to stimulation by EGF.

We conclude that endogenous K-Ras is the

predominant mediator of EGF-induced activation of ERK, whereas H-Ras has no
significant role in ERK activation in response to EGF. These results support earlier
studies that demonstrated that C-Raf is more potently activated by K-Ras than any
other Ras isoform. These earlier studies used ectopic expression of an oncogenic
form of the Ras isoform to determine the efficacy of Ras isoform-specific mediated
C-Raf activation (Yan et al., 1998). Our new results now show that endogenous KRas is also a more potent activator of Raf/MEK/ERK pathway than H-Ras. We also
assayed another important Ras signaling pathway, PI3-K/Akt pathway. Previous
studies have shown that the ectopically expressed constitutively active form of HRas is a potent activator of the PI3-K/Akt pathway (Yan et al., 1998). However, our
data here show that neither GFP-GAP-CTH nor GFP-GAP-CTK expression
significantly inhibited Akt activation.

Unlike ERK activation, which is K-Ras

dependent, activation of Akt may be mediated by both K-Ras and H-Ras and/or NRas which we did not investigate. Therefore, preventing activation of a single Ras
isoform, with either GFP-GAP-CTH or GFP-GAP-CTK, still allows other Ras
isoforms to activate PI3-K/Akt. Moreover, PI3-K can also be activated directly by
the EGF receptor.

Our results could also indicate that PI3-K activation on the

plasma membrane, at low doses of EGF, is largely Ras-independent.

One

approach to test this hypothesis would be to express each GFP-RasGAP protein in
EGF receptor null cells, stimulate with growth factor, and assess phosphorylated
Akt levels. This will allow us to determine whether or not PI3-K activation is solely
dependent upon activation of the EGF receptor.

64

Perhaps, the most intriguing result yet was the observation of significantly
increased levels of phosphorylated Akt levels at 5 min. in EGF-stimulated cells that
express GFP-GAP-CTH181S. This data suggests that Akt activation is increased
on the plasma membrane when Ras activation on the Golgi is abrogated.

An

explanation for this result may be possible competition of PI3-K regulatory and
catalytic subunits for recruitment to the plasma membrane or Golgi. Activation of
PI3-K occurs through at least two independent mechanisms: binding of the catalytic
subunit of PI3-K, p110, to GTP-loaded Ras and binding of the regulatory subunit of
PI3-K, p85, to an activated receptor tyrosine kinase (RTK) which stimulates p110
activation (Krasilnikov, 2000). By blocking Ras activation on the Golgi, it is possible
that the translocation of PI3-K (p110/p85) is enhanced for direct activation by the
EGF receptor. In turn higher levels of PI3-K activation on the plasma membrane
leads to an increase in the levels of phosphorylated Akt.

Another potential

explanation could be a reduction in the plasma membrane accumulation of
phosphatases in response to abrogation of Ras-GTP on the Golgi. Phosphatases
such as PTEN, SHIP1, and SHIP2 can prevent the activation of Akt (Vivanco and
Sawyers, 2002); but, how RasGTP on the Golgi might regulate plasma membrane
delivery of such phosphatases is unclear.
4.3 Regulation of Endogenous Ras Activation
As previously reported, Ras activation mediated by the EGF receptor occurs
rapidly (Murakoshi et al., 2004; Zhao et al., 2007).

Immediately following EGF

stimulation, we observed Ras GTP-loading that endured until 20min before
returning to basal levels with maximum Ras activation by 2 min. Since RasGEFS
are responsible for the exchange of RasGDP for RasGTP (Bernards and Settleman,
2007), this data suggests that endogenous RasGEFs are rapidly recruited to the
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plasma membrane in response to activation of the EGF receptor. The subsequent
return of Ras activation to basal levels is a potential consequence of an upregulation of endogenous RasGAP activity as well as a down-regulation of
endogenous RasGEF activity.

In support of these results, earlier studies have

demonstrated an up-regulation of RasGAP activity dependent upon activated
growth factor receptors. For instance, upon binding of EGF, EGF receptors recruit
PLCγ which leads to the generation of DAG and InsP3 through the hydrolysis of
PIP2. This stimulates calcium release causing an increase or up-regulation in the
recruitment of the RasGAP CAPRI to the plasma membrane. Like CAPRI, the
RasGAP GAP1m is recruited to the plasma membrane due to production of PIP3
from the RasGTP-dependent activation of PI3-K (Lockyer et al., 2001; Lockyer et
al., 1999). p120RasGAP also binds to phosphorylated tyrosine sites of activated
platelet derived growth factor (PDGF) and EGF receptors (Kaplan et al., 1990;
Kazlauskas and Cooper, 1990; Soler et al., 1993). Our results generally support
these concepts that p120RasGAP mediated GTP hydrolysis of Ras requires
membrane recruitment. Specifically, we show that the expression of cytosolic GFPGAP does not alter endogenous RasGTP levels on the plasma membrane.
Recent reports have suggested that release of palmitoylated Ras isoforms
from the plasma membrane to the Golgi, due to a continuous depalmitoylation/repalmitoylation cycle, is required for EGF-induced Ras activation at the Golgi.
However, our results suggest that retrograde trafficking of Ras from the plasma
membrane to the Golgi does not account for the prolonged (EGF stimulation for
40min) accumulation of RFP-RBD on the Golgi. Targeting GAP by the HVR of HRas (GFP-GAP-CTH) to the plasma membrane significantly decreased the
accumulation of RFP-RBD on the plasma membrane but had no affect on RFP-RBD
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localization to the Golgi; yet, we were able to reduce RFP-RBD accumulation on the
Golgi by targeting GAP to the Golgi (GFP-GAP-CTH181S). These results suggest
that

Ras

activation

on

the

Golgi

is

independent

of

the

depalmitoylation/repalmitoylation cycle and may occur directly at the Golgi. These
results support a previous study where GFP-RBD was utilized to report Ras
activation on the Golgi and the dependence of Ras activation at this compartment
on Src. In T cells, a pathway for Ras activation on the Golgi involving the Srcdependent activation of phospholipase C-γ1 (PLC-γ1) has been proposed. This
pathway includes the translocation of the RasGEF RasGRP1 from the cytosol to the
Golgi where it activates Ras.
4.4 Biological Consequences of Endogenous Ras Signaling
Next, we investigated the ability of RasGAP proteins to modify cellular
growth. The expression of each RasGAP protein impeded cellular growth; however,
with varying efficiency.

RasGAP proteins targeted to endogenous H-Ras and K-

Ras nanoclusters (GFP-GAP-CTH and GFP-GAP-CTK) on the plasma membrane
significantly suppressed cellular growth with similar efficacy. RasGAP targeted to
H-Ras on the Golgi (GFP-GAP-CTH181S) suppressed cellular growth to a lesser
extent than GFP-GAP-CTH and GFP-GAP-CTK.

Therefore, we conclude that

activation of endogenous H-Ras and K-Ras on the plasma membrane is more
important for growth than Ras activation on the Golgi. Correlating these effects on
cellular growth with MAPK activation alone is difficult since only GFP-GAP-CTK
significantly reduced ERK activation, yet all 3 GFP-RasGAP constructs inhibited
growth to a greater or lesser extent.

It seems most probable that other Ras

effectors, which we did not assay, are required for cellular proliferation.
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Differential regulation of cellular proliferation by distinct pools of Ras
activation has been previously described.

Palmitoylation-deficient constitutively

active H-Ras targeted to bulk membrane or lipid rafts of the plasma membrane
similarly enhances cellular proliferation. In contrast, targeting this protein to the
Golgi with a KDEL receptor mutant (KDELr N193D) which traps the protein in the
Golgi does not enhance growth, but can sustain limited cellular growth.
Interestingly, our results support this report providing evidence of differential affects
of endogenous Ras activation at the plasma membrane and the Golgi on cellular
proliferation.
We also examined whether the expression of RasGAP proteins would alter
the cellular fate of PC12 cells. We showed that the expression of GFP-RasGAP
proteins significantly reduced the levels of differentiation in PC12 cells. Specifically,
GFP-GAP-CTH and GFP-GAP-CTK suppress cellular differentiation with similar
efficacy while GFP-GAP-CTH181S expression results in the most profound
suppression of PC12 differentiation. In striking contrast to cellular growth, we can
conclude that the activation of endogenous Ras on the Golgi is more important for
cellular differentiation than H- or K-Ras on the plasma membrane. Our results of
endogenous plasma membrane-localized Ras contrast with a previous study where
abrogation of endogenous Ras activation on the plasma membrane had no
inhibitory affect on cellular differentiation. However, differences in specificity may
likely account for this discrepancy.

We targeted the GAP catalytic domain of

p120RasGAP to specific Ras nanoclusters on the plasma membrane to assess
regulation of differentiation by H-Ras or K-Ras, whereas the aforementioned study
overexpressed the RasGAP CAPRI and failed to target the protein to specific sites
of Ras activation on the plasma membrane. Consequently, all Ras isoforms are
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subject to inhibition by CAPRI and the effects on individual Ras isoforms are
ignored.

Furthermore, oncogenic H-Ras tethered to the Golgi is sufficient to

enhance cellular differentiation.

Using a different approach, we confirm that

endogenous H-ras activation on the Golgi has a key role in cellular differentiation.
PC12 cells are established as a model system for signal specificity of the
MAPK pathway. Upon stimulation by NGF, the MAPK pathway (Raf/MEK/ERK) is
activated through the receptor tyrosine kinase TrkA giving rise to cellular
differentiation.

The MAPK pathway is also activated by EGF through the EGF

receptor which leads to cellular proliferation. How the MAPK network processes
these different inputs into specific biological outputs in PC12 cells has been studied.
The underlying cause for these opposite cellular fates (proliferation and
differentiation) is the differences in the dynamics of ERK activation.

EGF

stimulation of the MAPK pathway prompts transient ERK activation where as NGF
stimulation produces sustained ERK activation (Marshall, 1995). A proposed model
further explains the molecular interpretation of distinct ERK dynamics by immediate
early gene products (IEGs). When ERK activation is sustained, IEGs are stabilized
by ERK-catalyzed phosphorylation. Consequently, different genes dependent upon
sustained ERK activity are expressed (Murphy et al., 2002).

Furthermore, it is

believed that upstream of ERK acitivity lies a distinct set of positive and negative
regulators which are differentially activated by EGF and TrkA receptors, thereby
contributing to opposite cellular fates. Among these regulators are PKC and Raf
kinase inhibitory protein (RKIP), respectively (Santos et al., 2007). Interestingly,
abrogation of RasGTP on the Golgi significantly decreased differentiation revealing
that Ras activity on the Golgi is important for differentiation than RasGTP on the
plasma membrane.

Since RasGTP on the Golgi has been characterized by
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sustained Ras activation (Chiu et al., 2002), it seems likely that sustained Ras
activity on the Golgi is responsible for sustained ERK activity and therefore cellular
differentiation observed in PC12 cells.

As for cellular proliferation, however,

precisely which Ras signaling pathways are responsible is not clear from our work.
Finally, our work has focused on H-Ras and K-Ras. It would be interesting to
examine the effects of RasGAP on N-Ras activity. To accomplish this, we would
simply target the catalytic domain of p120RasGAP to nanodomains that occupy
GTP-loaded N-Ras. This can be done by fusing the HVR of N-Ras to the catalytic
domain of p120RasGAP. Generally, in plasma membrane localization studies, NRas has not been extensively studied, so less is known about the N-Ras
nanoclustering. Both H-Ras and N-Ras have been shown to signal from the Golgi.
A comparison study between these two Ras isoforms using GFP-RasGAP proteins
targeted to the Golgi would be interesting.
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